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ABSTRACT 
CANNABIS USE, SCHIZOTYPY, AND PERSONALITY: ASSOCIATIONS WITH 
CANNABIS-RELATED PROBLEMS AND EMOTION RECOGNITION 
 
Brittany Elizabeth Blanchard, B. S.  
 
Western Carolina University (April 2013)  
 
Director: Dr. Kia Åsberg 
Individuals with schizotypy often report more cannabis-related problems, which include 
cognitive, interpersonal, and social responsibility difficulties. Past studies have observed 
correlations between the factors of schizotypy (i.e., positive, disorganized, and negative) 
and the five-factor model of personality. Certain personality traits are also associated 
with cannabis use. Further, both schizophrenia-spectrum symptoms and cannabis use 
have been implicated in reduced ability to identify emotional facial expressions, which 
can lead to greater difficulties in social functioning. Therefore, the purpose of the current 
study is to better understand the associations between cannabis use, schizotypy, and 
personality. Additionally, this research aims to identify which of the aforementioned 
variables are most salient in individuals who experience cannabis-related problems and 
emotional identification deficits. The sample was comprised of 242 undergraduates 
attending Western Carolina University, and data were collected through self-report 
measures and an eye tracker.    
Results from bivariate correlations and non-parametric s atistics indicated that 
cannabis use was associated with higher disorganized schizotypy and total schizotypy, 
while the number of cannabis-related problems was significantly correlated to all factors 
 
vii 
 
of schizotypy. Cannabis use, cannabis-related problems, and schizotypy were associated 
with lower Agreeableness and Conscientiousness, as well as higher levels of 
Immoderation and Excitement-Seeking. Individuals who met criteria for cannabis 
dependence were significantly higher in Excitement-Seeking, but lower in Cooperation, 
Dutifulness, Achievement-Striving, and Cautiousness compared to those who do not 
experience cannabis-related problems. Similar to the deficits seen on the schizophrenia-
spectrum, cannabis use frequency was associated with decreased attention to the left 
visual field; moreover, cannabis-related problems were negatively correlated to attention 
to the eyes of most emotional faces. Personality traits such as Conscientiousness were 
associated with fixation on particular emotional features, as well as accuracy for 
identifying neutral faces.  Taken together, the results of the current study suggest that 
there are significant associations between cannabis use, schizotypy, and personality, and 
these variables play a role in cannabis-related problems and facial affect recognition 
processing. Therefore, prevention of these potential problems should target identification 
of schizotypal traits, abstinence from cannabis, and social skills building in adolescence 
and emerging adulthood.   
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CHAPTER ONE: INTRODUCTION 
Cannabis is the most used illicit substance in the world and is prevalent on college 
campuses (Caldeira, Arria, O'Grady, Vincent, & Wish, 2008). While cannabis has 
anxiolytic and analgesic properties (Morgan & Curran, 2008), cannabis use may induce 
also psychotic-like symptoms, especially among individuals at risk for schizophrenia-
spectrum disorders (Stirling et al., 2008). An issue c rrently faced by clinicians is the 
treatment of comorbid cannabis dependence in individuals with schizophrenia (Drake & 
Mueser, 2000), as this population abuses cannabis more than the general population 
(Green, Young, & Kavanagh, 2005).  When examining causation between psychosis and 
cannabis use, researchers have suggested bidirectional causation, with psychotic 
symptoms leading to cannabis use, and cannabis use inducing psychotic-like experiences 
(Ferdinand et al., 2005).  
When studying problems associated with the schizophrenia spectrum, such as 
cannabis abuse, it is helpful to study schizotypy, which is defined as the genetic 
vulnerability for schizophrenia (Meehl, 1962). According to the American Psychiatric 
Association’s Diagnostic and Statistical Manual, Fourth Edition, Text Revision, 
schizophrenia symptoms are categorized into three typ s: positive (e.g., hallucinations 
and delusions), disorganized (e.g., disorganized spech and behavior), and negative 
(flattened affect, avolition, and alogia; DSM–IV–TR; American Psychiatric Association, 
2000). Individuals with schizotypy possess traits expressed as attenuated forms of 
schizophrenia symptoms, which also include positive (e.g., magical thinking and ideas of 
reference), disorganized (e.g., odd speech and behavior), and negative traits (e.g., 
constricted affect and no close friends; Raine, Reynolds, Lencz, & Scerbo, 1994).  
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Assessing cognitive, behavioral, and social problems of individuals with schizotypy 
allows researchers to better understand the schizoprenia spectrum while avoiding 
possible confounds that arise when conducting reseach with psychotic populations, such 
as side effects from antispsychotic medication and hospitalization (Völter et al., 2012).  
While schizotypal traits are thought to be on a continuum leading to 
schizophrenia-spectrum disorders, some literature sggests that schizotypal traits may 
also be variants of normal personality as constructed by the five-factor model (Asai, 
Sugimori, Bando, & Tanno, 2011). Additionally, studies indicate that cannabis users and 
schizotypal individuals may share certain personality traits, including higher Openness to 
Experiences, as well as lower Agreeableness and Conscientiousness, than the general 
population (Flory, Lynam, Milich, Leukefeld, & Clayton, 2002; Ross, Lutz, & Bailley, 
2002) Research has also found that low Extraversion and high Neuroticism predicts later 
psychotic symptoms in individuals who frequently consume cannabis (Fridberg, Vollmer, 
O’Donnell, & Skosnik, 2011).  
The literature has shown that individuals on the schizophrenia spectrum and those 
with schizotypy report more negative effects, (e.g., abuse/dependence, interpersonal 
problems, psychotic-like experiences, and occupation l difficulties) related to substance 
use than the general population (Drake & Wallach, 1989). When Najolia, Buckner, and 
Cohen (2012) investigated the associations between n gative affective traits and cannabis 
use in a college sample, they found that certain trits, such as depression and anxiety, 
were significantly positively associated with cannabis-related problems, but this was only 
true in individuals with elevated schizotypal symptoms. In fact, some research indicates 
that college students with higher schizotypy scores experience two -to-five times more 
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cannabis-related problems than non-schizotypal indiv duals (Cohen, Buckner, Najolia, & 
Stewart, 2011).     
Given this sensitivity to cannabis-related problems, schizotypal individuals who 
use cannabis may also experience more social difficulties. Emotional facial recognition 
deficits are common among individuals with psychotic disorders (Levy, Holzman, 
Matthysse, & Mendell, 1993) and have also been report d among chronic cannabis users 
(Platt, Kamboj, Morgan, & Curran, 2010). Further complicating the understanding of this 
underlying deficit is its association to personality. Individuals high in Neuroticism tend to 
spend more time viewing the eyes of negative emotive faces, such as fearful expressions 
(Perlman et al., 2009). Emotion recognition is a crucial skill in social functioning, and 
deficits may contribute the social difficulties of psychotic and cannabis-using 
populations.   
This study will use the dimensional approach to evaluate associations between 
schizotypal traits, normal personality, and cannabis use in a nonclinical sample of college 
students. Additionally, this research aims to determine how well cannabis use, 
schizotypy, and the five-factor model of personality can predict cannabis-related 
problems, as well as understand the associations with emotion recognition processing 
deficits. The outcome of this research may help to better inform clinicians of the 
underlying factors most associated with cannabis-related problems and deficits in 
emotion recognition so that treatment can be targeted toward these variables.    
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CHAPTER TWO: LITERATURE REVIEW 
Cannabis  
Cannabis, commonly called marijuana, is the most used illicit substance in the 
world and is prevalent throughout the United States (Copeland & Swift, 2009). 
According to the Substance Abuse and Mental Health Services Administration 
([SAMHSA], 2011), approximately 17.4 million Americans used cannabis in 2010. 
Individuals ages 18 to 25 use cannabis more than other age groups, with 18.5% of that 
age range reporting cannabis consumption in the past month. In addition to the increasing 
prevalence rates in the United States since 2002, individuals are now older on average 
when they first use cannabis (SAMHSA, 2011). Cannabis use is prevalent on college 
campuses (Caldeira et al., 2008; Gledhill-Hoyt, Lee, Striate, & Wechsler, 2000), with 
some studies estimating that approximately 30% of college students have consumed 
cannabis within the past year (Johnston, O’Malley, Bachman, & Schulenberg, 2011).  
Physiological effects of cannabis. This high prevalence of cannabis use may be 
due to its perceived positive effects (Johnson, Mullin, Marshall, Bonn-Miller, & 
Zvolensky, 2010) and facilitation of social interaction (Beck et al., 2009). According to 
the DSM-IV-TR, cannabis intoxication “begins with a ‘high’ feeling followed by 
symptoms that include euphoria with inappropriate lughter and grandiosity, sedation, 
lethargy, impaired judgment, distorted sensory perceptions, impaired motor performance, 
and the sensation that time is passing slowly. Occasion lly, anxiety, dysphoria, or social 
withdrawal occurs,” (4th ed., text rev.; DSM–IV–TR; American Psychiatric Association, 
2000, p. 237).  Cannabis intoxication may also be accompanied by perceptual 
disturbances and magical thinking (Martinotti et al., 2011). Because these symptoms are 
12 
 
 
often seen in individuals on the schizophrenia-spectrum, it appears that cannabis use may 
induce cognitive and behavioral effects resembling psychotic disorders (Koethe, Hoyer, 
& Leweke, 2009).   
Cannabis contains delta-9- tetrahydrocannabinol (∆9-THC), which increases 
dopamine activity and can lead to effects such as psychomotor retardation, reduced social 
understanding, lack of spontaneity, blunted affect, and emotional withdrawal (D’Souza et 
al., 2004). Johns (2001) revealed that in higher doses, ∆9-THC increases anxiety, 
alertness, depression, and tension. Koethe and researchers (2006) also found that ∆9-THC 
induces effects resembling positive symptoms of schizophrenia. There are other 
cannabinoids in cannabis, including cannabidiol, which may counter the psychotic-like 
effects of ∆9-THC through anxiolytic and antipsychotic properties (Morgan & Curran, 
2008). This is supported by the findings of Fusar-Poli and researchers (2009) which 
demonstrated that after ingestion of ∆9-THC, participants were more anxious and 
exhibited more psychotic symptoms, while administration of cannabidiol tended to 
decrease anxiety.  
Although some researchers support the notion of “cannabis psychosis,” and 
cannabis-induced psychotic disorder is listed in the DSM-IV-TR (DSM–IV–TR; 
American Psychiatric Association, 2000), many studies suggest that cannabis-induced 
psychosis is not categorical, but rather an early sign of schizophrenia (D’Souza, Sewell, 
& Ranganathan, 2009). This is corroborated by the fact that the majority of cannabis 
users do not experience psychotic reactions. Stirling and colleagues (2008) noted that 
psychotic-like symptoms induced by cannabis were predicted by high scores on 
psychosis-proneness measures. Sensitivity to psychotomimetic effects (i.e., effects which 
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mimic the presentation of psychosis) of cannabis may be an indication of genetic 
vulnerability for psychotic disorders (Genetic Risk and Outcome in Psychosis [GROUP] 
Investigators, 2011). 
Schizophrenia-Spectrum Disorders 
As noted, schizophrenia, which affects approximately 1% of individuals 
worldwide, (DSM–IV–TR; American Psychiatric Association, 2000) is marked by a 
heterogeneous assortment of positive, disorganized, and negative symptoms. The positive 
symptoms include hallucinations and delusions. The DSM-IV-TR includes disorganized 
speech, (such as frequent derailment or incoherence), and grossly disorganized or 
catatonic behavior as possible disorganized symptoms (DSM–IV–TR; American 
Psychiatric Association, 2000). Negative symptoms may anifest as restricted affect, 
avolition, and asociality (DSM–IV–TR; American Psychiatric Association, 2000). 
According to the proposed changes of the upcoming DSM-V, psychotic disorders will be 
now be labeled schizophrenia-spectrum disorders, which would include schizophrenia, 
schizophreniform disorder, brief psychotic disorder, delusional disorder, schizoaffective 
disorder, substance-induced psychotic disorder, psychotic and catatonic disorders 
associated with a known general medical condition, other specified psychotic disorder, 
and the schizotypal personality disorder (STPD; American Psychiatric Association, 
2011).  Two of these disorders are of particular interest to the current study and will be 
discussed next. 
Schizotypal Personality Disorder. The prevalence of STPD is slightly greater 
than that of schizophrenia, occurring in roughly 3%of the population (DSM–IV–TR; 
American Psychiatric Association, 2000). Prodromal phases of schizophrenia may be 
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characterized by negative symptoms or attenuated positive symptoms, such as odd beliefs 
and bizarre perceptual experiences (DSM–IV–TR; American Psychiatric Association, 
2000). This presentation is similar to that of schizotypal personality disorder, as both 
pathologies include magical ideation, interpersonal difficulties, eccentric behavior, and 
cognitive-perceptual alterations.  Although individuals with prodromal schizophrenia 
symptoms are at a greater risk for later developing schizophrenia, (Bedwell & Donnolly, 
2005), STPD is more prevalent in individuals related to those with schizophrenia-
spectrum disorders (Kendler & Gardner, 1997). This suggests a strong genetic component 
associated with the continuum of psychotic disorders. 
“The essential feature of schizotypal personality dsorder is a pervasive pattern of 
social and interpersonal relationships marked by acute discomfort with, and reduced 
capacity for, close relationships as well as by cognitive or perceptual distortions and 
eccentricities of behavior,” (DSM–IV–TR; American Psychiatric Association, 2000, p. 
697). The proposed DSM-V classification of STPD is comprised of three types of broad 
symptom domains: psychoticism, (e.g., eccentricity, ognitive and perceptual 
dysregulation, unusual beliefs and experiences), detachment, (e.g., restricted affectivity 
and withdrawal), and negative affectivity, (e.g., suspiciousness; American Psychiatric 
Association, 2011). The social deficiencies associated with STPD are similar to, but less 
severe than, social deficits in schizophrenia (Dickey et al., 2011), corroborating the 
notion of a schizophrenia-spectrum. In non-clinical ndividuals, the attenuated 
presentation of STPD characteristics is categorized as schizotypy. 
Schizotypy. Within the general population, schizotypy, defined as a genetic 
vulnerability for schizophrenia-spectrum pathology (Meehl, 1962), and is marked by odd 
15 
 
 
thinking, perceptual aberrations, social withdrawal, and suspiciousness (Esterberg, 
Goulding, McClure-Tone, & Compton, 2009). The currently accepted model involves 
three factors:  positive (e.g., magical thinking, ideas of reference, unusual perceptual 
experiences), negative (e.g., constricted affect, no close friends, social anxiety), and 
disorganized (e.g., odd speech and behavior; Raine, Reynolds, Lencz, & Scerbo, 1994). 
Schizotypal symptoms are similar to that of prodromal schizophrenia, except these traits 
tend to be stable (Bedwell & Donnolly, 2005). 
There are two approaches to quantifying schizotypy. The first is the categorical or 
taxometric conceptualization (Meehl, 1962), in which only the top scoring individuals on 
a measure of schizotypy within a population are at greater risk of developing 
schizophrenia. This is approximately 10% of the general population (Lenzenweger & 
Korfine, 1992). Within college populations, studies have found the prevalence of clinical 
schizotypal scores to be slightly less than in the general population, at approximately 6% 
(Cohen et al., 2011). According to the alternative approach, the dimensional 
conceptualization, schizotypy is linear and exists on a continuum (Mason & Claridge, 
1994). This conceptualization of schizotypy is supported by the fact that traits comprising 
psychosis proneness greatly resemble attenuated symptoms of schizophrenia and STPD 
(Nunn, Rizza, & Peters, 2001). While this dimensional approach theorizes that 
schizotypy is on a personality continuum with schizophrenia-spectrum disorders 
(Williams, Wellman, & Rawlins, 1996), others theorize that schizotypy may exist on the 
continuum of normal personality traits (Asai, Sugimori, Bando, & Tanno, 2011). 
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Personality  
Currently, the most accepted conceptualization of normal personality is the five-
factor model (Costa & McCrae, 1995). This model entails five broad factors of 
personality, (i.e., Neuroticism, Extraversion, Openn ss to Experience, Agreeableness, and 
Conscientiousness), each consisting of six underlying facets. While the NEO-PI-R is the 
frequently used to measure the five-factor model of personality, the M5-120 is a 
comparable measure which produces the same five factors and 30 facets, although some 
facets differ in labeling (McCord, 2002). For a list of M5 domains and corresponding 
facets, as well as differing facet names for the NEO-PI-R, see Table 1.    
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Table 1. 
M5 Domains and Facets (with Corresponding NEO-PI-R Facets in Parentheses) 
Neuroticism 
-Anxiety 
-Anger (Angry Hostility) 
-Depression 
-Self-Consciousness 
-Immoderation (Impulsiveness) 
-Vulnerability 
 
Extraversion 
-Friendliness (Warmth) 
-Gregariousness 
-Assertiveness 
-Activity 
-Excitement-Seeking 
-Cheerfulness (Positive Emotions) 
 
Openness to Experience 
-Imagination (Fantasy) 
-Artistic Interests (Aesthetics) 
-Emotionality (Feelings) 
-Adventurousness (Actions) 
-Intellect (Ideas) 
-Liberalism (Values) 
 
Agreeableness 
-Trust 
-Morality (Straightforwardness) 
-Altruism 
-Cooperation (Compliance) 
-Modesty 
-Tendermindedness 
 
Conscientiousness 
-Self-Efficacy (Competence) 
-Order 
-Dutifulness 
-Achievement-Striving 
-Self-Discipline 
-Cautiousness (Deliberation) 
Personality and schizophrenia-spectrum. There has been much research 
focusing on the associations between the schizophrenia-spectrum and normal personality 
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traits. For example, a meta-analysis of the literature indicated that individuals with 
schizophrenia are often neurotic and introverted (Berenbaum & Fujita, 1994). 
Schizophrenia is also associated with lower Agreeableness (Gurrera, Nestor, O’Donnell, 
Rosenberg, & McCarley, 2005). By asking STPD researchers to identify a typical 
schizotype, Lynam and Widiger (2001) noted that these individuals are described as high 
in Openness to Ideas and Self-Consciousness; furthermor , the protypical schizotype was 
considered low in Positive Emotion, Warmth, and Grega iousness (Lynam & Widiger, 
2001). Additionally, schizotypal traits sometimes coincide with less Agreeableness and 
Conscientiousness (Coolidge et al., 1994). Although STPD correlates with higher 
Openness, schizophrenia-spectrum personality disorders often demonstrate personality 
profiles similar to, but more attenuated than, the pattern of characteristics seen in 
schizophrenia (Camisa et al., 2005). 
Personality and schizotypy. Individuals with schizotypal traits often possess 
certain personality traits, based on the five-factor m del. For example, several studies 
have shown that schizotypal individuals tend to have elevated Neuroticism and low 
Agreeableness (Ross, Lutz, & Bailley, 2002).  More sp cifically, positive schizotypal 
symptoms are associated with higher Extraversion and Openness (Barrantes-Vidal, 
Lewandowski, & Kwapil, 2010). Disorganized symptoms often correlate positively with 
Neuroticism (Kerns, 2006) and Openness to Experience (Fridberg et al., 2010), while 
negative schizotypal symptoms are predicted by lower Extraversion, Agreeableness, and 
Openness (Ross, Lutz, & Bailley, 2002). 
On the facet level, there are also associations between schizotypy and personality. 
Literature on this topic suggests that at the facet level, schizotypy is associated with 
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higher Anxiety and Self-Consciousness, but lower Positive Emotions, Warmth,  
Gregariousness, and Trust (Edmundson & Kwapil, 2013). Ross and associates (2002) 
found a positive correlation between Depression, Impulsiveness, Excitement-Seekeing, 
Tendermindedness, Fantasy, and Aesthetics, as well as a negative correlation with Trust 
and Straightforwardness in positive schizotypy. This contrasts with negative schizotypy, 
which is positively associated with Hostility and Self-Consciousness but is negatively 
correlated to Anxiety, Impulsiveness, Aesthetics, Feelings, and Actions facets (Ross et 
al., 2002).       
 The precise association between personality and schizotypy remains unclear. 
While some researchers suggest that schizotypal traits c n be conceptualized as 
maladaptive versions of normal personality characteistics (Edmundson, Lynam, Miller, 
Gore, & Widiger, 2011), new literature on schizotypy and the five-factor model  indicates 
that the association between the two may be linear. This research suggests that schizotypy 
is fully-dimensional and on continuum of normal personality, with more extreme 
presentations of Neuroticism and Extraversion (Asai, Sugimori, Bando, & Tanno, 2011). 
This is consistent with findings that healthy cannabis users with higher Neuroticism and 
lower Extraversion are at an increased risk for psychosis as they age (Fridberg et al., 
2011).  
Personality and cannabis use. Frequent cannabis users differ from non-using 
samples on measures of broad personality domains (Terracciano, Löckenhoff, Crum, 
Bienvenu, & Costa, 2008). Generally, cannabis use is associated with above Openness to 
Experience, low Agreeableness, and low Conscientiousness (Fridberg et al., 2011). 
Although Neuroticism and Extraversion are often aver g  in cannabis users, Terracciano 
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and colleagues (2008) found that this population exhibits higher Angry Hostility and 
Vulnerability, which are two Neuroticism facets, as well as higher Activity and 
Excitement-Seeking. Within Openness to Experience, cannabis users score higher in 
Values and Ideas, but score lower in the Agreeableness facet of Compliance and lower in 
the Conscientiousness facets of Dutifulness and Deliberation (Terracciano et al., 2008).  
When researching correlates of cannabis abuse and depen ence symptoms, Flory 
and colleagues (2002) found that an association between these signs of problematic use 
and high Neuroticism, low Agreeableness and low Conscientiousness; however, after for 
controlling for comorbid psychopathologies (e.g., antisocial personality disorder and 
internalizing psychopathology symptoms), only low Extraversion and high Openness 
were correlates of cannabis abuse/dependence symptoms. Additionally, cannabis users 
with higher Neuroticism, higher Openness, and lower Ext aversion are at a higher risk for 
negative schizotypal symptoms (Fridberg et al., 2011). Because cannabis users and 
individuals on the schizophrenia spectrum tend to possess similar personality traits, (e.g., 
low Agreeableness, low Conscientiousness, and higher Neuroticism on specific facets) 
and cannabis users with particular personality profiles are thought to be at an increased 
risk for psychosis, it is important to address the complex relationship between the two. 
Cannabis Use and the Schizophrenia Spectrum  
  Individuals on the schizophrenia-spectrum abuse cannabis at higher rates than the 
general population (Green, Young, & Kavanagh, 2005). Although many studies have 
focused on cannabis use in individuals with schizophrenia-spectrum disorders and 
psychosis proneness, the precise association remains unclear. Arendt, Rosenberg, 
Foldager, Perto, & Munk-Jørgensen (2005), suggested that individuals with 
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schizophrenia who use cannabis may experience their first psychotic episode at an earlier 
age than non-users, given that cannabis-induced psycho is predicted later schizophrenia-
spectrum disorders in nearly half of their sample. Similarly, others hypothesize that 
cannabis use may provoke the onset of psychosis (González-Pinto et al., 2011). In fact, 
several studies suggest that cannabis use may be a component in the development of 
psychotic disorders, (Arseneault, Cannon, Witton, & Murray, 2004; Moore et al., 2007), 
though others dispute this claim (Phillips et al., 2002). Ferdinand and researchers (2005) 
suggested bidirectional causation, with psychotic symptoms leading to cannabis use, and 
vice versa. The association between cannabis use schizotypy is also marked by 
inconsistent findings (Compton, Chien, & Bollini, 2009).   
Cannabis use and schizotypal symptoms. Much of the literature suggests that 
schizotypy is positive correlated with cannabis use (Esterberg et al., 2009; Rössler, 
Hengartner, Angst, & Ajdacic-Gross, 2012; Williams et al., 1996). While examining the 
connection between cannabis use and schizotypal personality traits, Mass, Bardong, 
Kindl, and Dahme (2001) found that cannabis users have igher scores on schizotypal 
personality measures than controls in college populations; furthermore, duration of 
cannabis use is positively associated with self-report d schizotypal symptoms (Fridberg 
et al., 2010). Although no consensus can be establihed on the associations between 
cannabis use and positive, negative, and disorganized schizotypal symptoms, general 
trends emerge from the literature. 
Cannabis use and positive symptoms. Several studies have reported that 
cannabis use is associated with increased positive chizotypy symptoms (Nunn et al., 
2001; Skosnik, Spatz-Glenn, & Park, 2001). Moreover, the severity of positive 
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schizotypy is positively correlated to the amount of self-reported cannabis use weekly 
(Skosnik, Park, Dobbs, & Gardner, 2008). Positive symptoms are also associated with 
onset of cannabis use, with younger onset users reporting more positive schizotypal traits 
(Skinner, Conlon, Gibbons, & McDonald (2011). Barkus and Lewis (2008) reported that 
among non-clinical college students, those with high scores on a measure of schizotypy 
who also consumed cannabis experienced more psychotic symptoms during and after use. 
Cohen and associates (2011), however, did not find the link between cannabis use and 
increased positive symptoms to be exclusive to indiv duals with clinically-elevated 
schizotypy. This suggests that increased self-report d positive schizotypal symptoms may 
be a function of cannabis use and not strictly a predictor of later psychosis.  
Cannabis use and disorganized symptoms. Previous research has indicated a 
positive association between cannabis use and disorganized schizotypy symptoms, with 
current users reporting more disorganized symptoms than previous and non-users (Barkus 
& Lewis, 2008). This positive association between ca nabis use and disorganized 
schizotypy has also been found in samples of undergraduates (Bailey & Swallow, 2004; 
Schiffman, Nakamura, Earleywine, & LaBrie, 2005). Similarly, Esterberg and coworkers 
(2009) found that higher disorganized schizotypal symptoms predicted an increased risk 
for substance use and was significantly correlated to cannabis consumption. Associations 
between cannabis use and negative schizotypal symptoms have also been reported.   
Cannabis use and negative symptoms. In individuals with schizophrenia, there 
is an inverse association between cannabis abuse and negative symptoms (Dubertret, 
Bidard, Adès, & Gorwood, 2006). When investigating the association between ultra-high 
schizophrenia risk and cannabis use, Machielsen, van der Sluis, and de Haan (2010) 
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found that pre-psychotic negative symptoms were negatively correlated to cannabis 
consumption. Skosnik and colleagues (2008) found that the cannabis users had lower 
negative schizotypy symptom scores than healthy controls, which has been corroborated 
by several previous studies (Nunn et al, 2001; Schiffman et al., 2005). Similarly, Cohen 
and colleagues (2011) found this inverse association between cannabis and negative 
symptoms in a college population, but only in indivi uals with schizotypy. If cannabis 
use is decreasing perceived negative schizotypal symptoms, this may be one explanation 
for the high prevalence in the comorbidity of schizotypy and cannabis use.    
Proposed Associations between Cannabis Use and Schizophrenia-Spectrum  
There are multiple theories which attempt to explain the association between 
cannabis use and schizophrenia-spectrum disorders. Dumas and colleagues (2002) 
suggested three possible pathways to comorbid schizotypal traits and cannabis use: 
schizotypal traits are exacerbated by cannabis use in high risk individuals, cannabis use is 
a form of self-medication for schizotypal traits, or the presence of an etiopathiological 
component leading to both.  Similarly, Potvin, Stip, and Roy (2003) hypothesized that 
there are two directions for this complex association, with cannabis use exacerbating 
positive symptoms in individuals on the psychotic spectrum, and cannabis being used to 
alleviate negative symptoms. While heightened positive symptoms can be explained by 
the dopamine hypothesis of schizophrenia, alleviation of negative symptoms is more 
congruent with self-medication models.  
Dopamine hypothesis and the supersensitivity model. The primary 
psychoactive component of the cannabis sativa plant, ∆9-THC, mimics natural 
cannabinoids found in the body, such as anandamide, which can lead to hyperactive 
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dopaminergic activity (D’Souza et al., 2009). Seeman (2011) indicated that 
supersensitive dopamine receptors may be the underlying factor in psychotic symptoms. 
Because the effects of cannabis are similar to positive symptoms of schizophrenia, the 
cannabinoid model of psychosis was proposed, in which those at risk for schizophrenia 
have dysregulated endocannabinoid receptors (Skosnik et al., 2001). When exploring the 
dopamine hypothesis of schizophrenia, Hirvonen and Hietala (2011) found that the 
dopaminergic alternations seen in individuals with sc izophrenia are also found in 
individuals at genetic risk; therefore, they propose a “dopamine hypothesis of 
schizophrenia vulnerability,” (p. 93). Research indicates that psychotic-like and 
dysphoric experiences from cannabis use by individuals on the schizophrenia spectrum 
are likely due to dopamine system sensitivity (Stirling et al., 2008). Individuals on the 
schizophrenia spectrum may be vulnerable to the rewarding effects of cannabis, by means 
of hypersensitive dopamine systems (Potvin et al., 2003). 
The supersensitivity model (Mueser, Drake, & Wallach, 1998) is based on the 
stress-vulnerability model of schizophrenia (Nuechtrlein & Dawson, 1984). From the 
theory that individuals with schizophrenia have genetic vulnerabilities which react 
differently to environmental stress, the supersensitivity model posits that these 
individuals are also especially sensitive to the eff cts of certain psychoactive substances, 
even with less use than the general population (Gregg, Barrowclough, & Haddock, 2007). 
While this is corroborated by findings of increased positive schizotypal symptoms with 
cannabis use, this model cannot explain why cannabis users report less negative 
schizotypy symptoms than their non-using counterparts in emerging adulthood 
populations (Skosnik et al., 2008). 
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Self-medication and alleviation of dysphoria models. The self-medication 
model of cannabis use has been supported (Hambrecht & Häfner, 1996) and refuted 
(Welch et al., 2011) throughout the literature. This model proposes that cannabis is used 
to reduce negative schizophrenia-spectrum symptoms; however longitudinal (González-
Pinto et al., 2009) and meta-analyses of self-reports do not suggest long-term evidence 
for self-medication effects (Compton, Goulding, & Walker, 2007). Contrarily, there is 
evidence indicating that individuals with schizophrenia who also use cannabis exhibit 
significantly fewer negative symptoms, although frequ ncy of hallucinations increase 
with cannabis use (Dubertret et al., 2006). A broader conceptualization of the self-
medication model, the alleviation of dysphoria hypothesis (Mueser et al., 1998), may be 
more accurate in depicting the association between can abis use and negative 
schizophrenia-spectrum symptoms.  
The alleviation of dysphoria model proposes that severe mental illness and 
substance use co-occur because this population is trying to minimize negative affect 
(particularly boredom, depression and loneliness), and enhance pleasure (Kolliakou, 
Joseph, Ismail, Atakan, & Murray, 2011). While this is consistent with reported motives 
of schizophrenia patients who use cannabis (e.g., to reduce boredom, enhance 
socialization, improve socialization, and reduce negative affective states; Schofield et al., 
2006), this model cannot explicate why individuals with schizotypy report more 
cannabis-related problems than the general public (Cohen et al., 2011; Najolia et al., 
2012).  
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Cannabis-Related Problems  
The general term cannabis-related problems often refer to the physiological, 
social, occupational, and abuse/dependence consequences associated with cannabis use. 
According to ICD-10 criteria, harmful use consists of “a pattern of psychoactive 
substance use that is causing damage to health,” (World Health Organization, 2013, p. 4); 
further, dependence criteria consists of three or mre of the following: compulsion to use 
the substance, difficulties controlling substance intake, withdrawal, evidence of tolerance, 
neglect of other interests, and persistent use despite obvious detrimental consequences 
(World Health Organization, 2013).  In otherwise healthy volunteers, Simons and Carey 
(2002) found a correlation between cannabis use-related problems and frequency was 
strongest in individuals with affect dysregulation problems; furthermore, they noted that 
the correlation between frequency of use and cannabis-related problems was strengthened 
by impulsivity.  
Substance-related problems and poorer psychosocial functioning are often 
reported more frequently in individuals with schizophrenia-spectrum disorders 
([Compton, Simmons, Weiss, & West, 2011; Drake & Wallach, 1989], as well as 
schizotypy (Cohen et al., 2011). In a large sample of undergraduate students, immediate 
cannabis-induced psychotic-like experiences were predicted by high schizotypy (Stirling 
et al., 2008). Additionally, Cohen and researchers (2011) found that individuals with 
higher levels of schizotypy report two to five times more cannabis-related problems than 
others, suggesting a unique adverse effect of cannabis on those who are psychosis-prone. 
In a college sample, Najolia and associates (2012) found that while depression, social 
anxiety, and trait anxiety were negatively associated with cannabis use frequency in the 
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control group, these traits were significantly positively correlated to cannabis-related 
problems in individuals with higher schizotypy scores. 
Taken together, these data corroborate the supersensitivity model, which 
postulates that individuals at risk for the schizophrenia spectrum may be more vulnerable 
to the negative consequences of cannabis use, due to heightened sensitivity to its effects. 
If this is correct, then certain emotional processing deficits, which are seen in individuals 
on the schizophrenia-spectrum (Benson, Leonards, Lothian, St. Clair, & Merlo, 2007), as 
well as individuals who use cannabis (Platt et al., 2010) should be exhibited in 
individuals with schizotypal traits who use cannabis. Further, it may be that underlying 
personality traits, such as depression and anxiety, which are also seen positively related 
to schizotypy and cannabis-related problems, also contribute to social difficulties. 
Emotion Recognition and Eye Tracking Deficits 
Emotion recognition is an important aspect of social cognition, which broadly 
encompasses how individuals process information about the self and others (Myers, 
2007). The skill of processing and accurately interpr ting emotional facial expressions is 
a crucial component in social interaction. Throughout the literature, this skill is often 
assessed through tracking eye movements, as the ability to determine emotions from 
facial expressions involves correctly interpreting visual information (Ruhrmann et al., 
2012). Individuals on the schizophrenia spectrum and cannabis users commonly exhibit 
emotional recognition labeling and eye tracking dysfunctions (Benson et al., 2007; Platt 
et al., 2010; Waldeck & Miller, 2000).  
Research suggests that exploratory eye movements and eye tracking dysfunctions 
are potential endophenotypes that may be used by clinicians to evaluate individuals on 
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the schizophrenia spectrum (Ishii, Morita, Shouji, Nakashima, & Uchimura, 2010; 
Phillips & David, 1997). Eye tracking dysfunctions have been seen in psychotic 
individuals, as well as some of their non-clinical family members (Levy et al., 1993). 
Lenzenweger and O’Driscoll (2006) confirmed the link between eye tracking dysfunction 
and schizotypal traits in a nonclinical population, further supporting the idea of eye 
tracking dysfunction as a biological marker of schizophrenia-spectrum liability. 
Individuals exhibiting schizotypal personality trais are associated with slowness and 
inaccuracy when identifying facial expressions (Dickey et al., 2011; Germine & Hooker, 
2010). Research by Waldeck and Miller (2000) indicated that subjects with STPD have 
deficits in positive emotion processing. In a study of eye tracking performance, 
Mitropoulou and researchers (2011) found that individuals with schizophrenia and STPD 
perform worse at tracking constant velocity trapezoids than healthy controls; moreover, 
the individuals with STPD tended to perform worse than controls, but better than those 
with schizophrenia, suggesting a continuum of impairment. Individuals with 
schizophrenia and those clinically at risk for the development of psychosis often display 
more aberrant and limited scanpaths, which has beenfound to be associated with lower 
social functioning (Ruhrmann et al., 2012).  
 A scanpath is a mapped representation of saccades an  gaze fixations, including 
length and direction (Noton & Stark, 1971). A saccade is the rapid, simultaneous 
movement of both eyes, while a gaze fixation occurs when the eyes linger for roughly 
200-300 milliseconds between saccades (Rayner, 1998). Green, Waldron, Simpson, and 
Coltheart (2008) found limited scanning and increased gaze fixation in patients with 
schizophrenia, as well as delayed staring at faces in social contexts, suggesting a 
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restricted visual processing of faces. Additionally, research has indicated that individuals 
with schizophrenia may fixate on specific areas when vi wing affective faces, but their 
gaze patterns suggest that they do no focus on the overall area (Ishii et al., 2010). Further, 
individuals with schizophrenia often exhibit limited scanning in the left visual field, 
particularly for happy and neutral faces (Loughland, Williams, &Gordon, 2002). Using a 
continuous approach to scan path changes, Benson and researchers (2007) examined 
differences in eye tracking dysfunction between cannabis-induced psychosis and first-
episode schizophrenia patients. They found that both groups made fewer saccades and 
fewer fixations of longer duration compared to contr ls, but the cannabis-induced 
psychosis group showed less diversity in emotional features on which they fixated 
compared to schizophrenia and control groups. Overall, the results suggest that 
individuals with schizotypy should exhibit limited scanpaths, marked by fewer saccades 
and fixations, especially on non-negative emotional stimuli. 
Lateralization preferences. Within the general population, a tendency emerges 
to shift the eyes leftward when viewing emotional stimuli, which is associated with right 
hemispheric function of the brain (Schwartz, Davidson, & Maer, 1975). While healthy 
controls are biased toward viewing the left side of the face first, Phillips and David 
(1997) found that patients with schizophrenia often viewed and focused on the right side 
of faces first, which they suggested may be due to right hemispheric dysfunction in 
schizophrenia. Interestingly, they also found that patients who first viewed the left side of 
faces tended to fixate on the left side of the face, indicating inflexibility in visual 
scanning paths (Phillips & David, 1997).  
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Regarding schizotypy and processing of emotion stimuli, the literature seems to 
be incongruent with the schizophrenia-spectrum hypothesis. While Leonards and Mohr 
(2009) found no association between facial processing biases and negative schizotypy, 
positive schizotypal symptoms were positively correlated with a leftward bias in the first 
saccade direction in processing facial features. Because negative schizophrenia symptoms 
are associated with less exploratory eye movements (Nishiura, Morita, Kurakake, Igimi, 
& Maeda, 2007), especially in the left visual field (Ishii et al., 2010), it may be that 
positive schizotypy is associated with a left side pr ference, while rightward biases may 
reflect negative schizophrenia-spectrum traits that were too attenuated to be significant in 
schizotypal studies. Alternatively, the deficits in emotion recognition observed in 
schizotypy, as well as cannabis users, may be better explained by a trait-congruency 
information processing perspective. 
Trait-congruency perspective. When viewing faces the general population often 
focuses on the mouth, eyes, nose, and ears (Rayner, 1998); in addition, healthy 
individuals more readily identify faces depicting positive affect (Rotenberg, 2011). 
Research suggests that individuals tend to interpret information, particularly emotional 
information, in a way that is consistent with indivi ual characteristics (Bargh, Lombardi, 
& Higgins, 1988). For example, individuals high in Neuroticism tend to make more 
saccades to the eye region when viewing fearful faces (Perlman et al., 2009). Loughland 
and researchers (2002) noted that schizophrenic patients paid more attention to facial 
features in sad faces but showed fewer fixations and less attention to prominent features 
in happy and neutral faces. Additionally, cannabis users take longer to identify emerging 
emotionally-charged faces, and they more readily label  neutral face as sad (Platt et al., 
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2010). This negative bias is also seen in depressed individuals (Beevers, Wells, Ellis, & 
Fischer, 2009), which suggests that underlying negative ffectivity (e.g., Neuroticism) 
may better account for emotion recognition problems.    
Present Study 
 Genetic, psychological, and environmental factors may put vulnerable individuals 
at risk for cannabis consumption and schizophrenia-spectrum disorders, particularly 
during young adulthood (Gregg et al., 2007). Given the complex nature of the interaction, 
the current study aims to better understand the association between cannabis use, 
schizotypy, and personality, as well as their associati n to cannabis-related problems and 
emotional recognition deficits in a non-clinical young adult population. The following 
hypotheses and research questions will be explored:  
Hypothesis One: Users of cannabis in the last 6 months will report more positive 
and disorganized schizotypal symptoms, but less negative schizotypal symptoms than the 
never-using group. 
Hypothesis Two: Positive correlations are expected between cannabis use 
frequency, cannabis-related problems, and schizotypy total, positive, and disorganized 
scores. Negative schizotypy scores are expected to be negatively associated with cannabis 
use frequency and cannabis-related problems.  
Hypothesis Three: Users of cannabis in the last 6 months will be lower in 
Agreeableness and Conscientiousness compared to non-users. Further, positive 
correlations are expected between cannabis use frequency and Openness to Experience, 
as well as its underlying facets. Negative correlations are expected between cannabis use 
frequency and Agreeableness, Conscientiousness, and their respective facets. On the facet 
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level of Neuroticism, positive correlations are expcted between Anger, Vulnerability, 
and cannabis use frequency.  
Hypothesis Four: Positive, disorganized, and negative schizotypy will be 
positively associated with Neuroticism and its facets. Positive correlations are expected 
between positive and disorganized schizotypy and Openness to Experience, although a 
negative correlation is expected between this domain and negative schizotypy. 
Additionally, schizotypy subscales will be negatively associated with Agreeableness, 
Conscientiousness, Extraversion, and the respective facets of these domains.    
Research Question One: Can schizotypy and personality predict cannabis-related 
problems? 
Research Question Two: Are cannabis use, schizotypy, and personality 
associated with emotion processing deficits (i.e., accuracy in identifying emotional 
expressions) and preferential areas of interest (i.e., left versus right lateralization 
preference and fixation on features of certain emotional faces)? 
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CHAPTER THREE: METHOD 
Participants  
Participants consisted of psychology undergraduate students enrolled at Western 
Carolina University (N = 242). The total sample consisted of 63 males (26%) and 179 
females (74% of the sample). The majority of the sample (84.3%) identified themselves 
as White. Participants ranged from 18 to 37 years of age (M = 19.52, SD = 2.32). The eye 
tracker sample, which was comprised of 70 participants from the total sample, consisted 
of 52 females (74.3%) and 18 males (25.7%). These participants ranged in age from 18-
32, (M = 19.77, SD = 2.17). This data was gathered through basic demographic 
information obtained from each participant. These items included age, sex, ethnicity, 
college classification, and GPA. Demographic question  were administered last to control 
for potential gender and ethnicity stereotype effects (Danaher & Crandall, 2008).     
All participants reported normal or corrected vision. Course credit was given for 
the completion of the study. The collected data wasde-identified to protect participant 
confidentiality. Exclusion criteria included being less than 18 years of age and legal 
blindness, due to the eye tracking component of the s udy. This study was approved by 
the university’s Human Subject Review Board, and informed consent was obtained 
before administration of the self-report measures. Participants were then invited to 
complete the second portion of the study, the eye-tracker procedure, for which informed 
consent was also obtained.  
Measures  
 Cannabis use behaviors. The Cannabis Use Disorders Identification Test 
(CUDIT) was utilized to assess frequency of cannabis use in the last 6 months. A 
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modification of the Alcohol Use Disorders Identification Test (AUDIT), this 10-item 
self-report measure evaluates cannabis abuse and dependence based on DSM-IV criteria 
(Adamson & Sellman, 2003). The Problematic Use of Marijuana (PUM) is based on 
ICD-10 criteria for harmful cannabis use. This questionnaire consists of eight yes/no 
items and was used to evaluate lifetime prevalence of annabis-related problems. These 
include interpersonal, social responsibility, and cognitive difficulties (Okulicz-Kozaryn, 
2007). The PUM has an internal consistency coefficint of .92 and has been deemed 
appropriate for males and females, as well as different age groups (Piontek, Kraus & 
Klempova, 2008). In the current sample, the PUM exhibited acceptable reliability, with α
= .76.   
Schizotypal traits. The Schizotypal Personality Questionnaire-Brief Revis d was 
used to measure schizotypal traits (Cohen, Matthews, Najolia, & Brown, 2010). The 
SPQ-BR is comprised of 32 items selected from the original SPQ and quantifies 
cognitive-perceptual (i.e., positive), disorganized, and interpersonal (i.e., negative) traits. 
The SPQ-BR total score has excellent internal consistency, with a Cronbach’s alpha of 
.90. The factor scales produce acceptable-to-good internal consistency in college students 
(i.e., positive factor α = .79, disorganized factor α = .83, negative factor α = .86; Cohen et 
al., 2010). Reliability was good for the SPQ-BR in this sample, α = .89. The SPQ-BR 
utilizes a 5-point Likert-type scale, with response options ranging from “Strongly 
Disagree” to “Neutral” to “Strongly Agree.” Because the present study is based on the 
dimensional model of the schizophrenia spectrum, SPQ-BR scores from all participants 
were examined in analyses, similar to the methods of previous research by Wuthrich and 
Bates (2006). 
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The positive schizotypy factor is comprised of the Id as of Reference, 
Suspiciousness, Magical Thinking, and Unusual Perceptions subscales. The disorganized 
factor includes the Odd Speech and Eccentric Behavior subscales. Interpersonal or 
negative schizotypy is made up of the No Close Friends and Constricted Affect subscales. 
Although other SPQ measures include the Social Anxiety subscale (Raine et al., 1994), 
Cohen and researchers (2010) found that the 3-factor model excluding social anxiety was 
also reliable and may better represent schizotypy, as the prototypical schizotypal 
individual is thought to be socially anhedonic (Mishlove & Chapman, 1985). Because 
social anxiety is not a core constituent of schizotypy, the social anxiety symptoms will 
not be analyzed. Due to incomplete responding, weight d means were calculated for four 
items for 10 individuals, and one item for 1 indiviual. One participant skipped the 
second page of the SPQ-BR, so this participant’s score  for the SPQ-BR were eliminated 
from analyses. 
Personality. Participants completed the M-5 120, which measures th  following 
five broad factors of personality and their six corresponding facets: Neuroticism, 
Openness, Agreeableness, Conscientiousness, and Extraversion. The M-5 utilizes a five-
point Likert-type scale, with one being “Very Inaccurate” and five being “Very 
Accurate.” The 120 items are divided equally with 24 questions per domain and four 
questions per individual facet (Johnson, 2001). While previous findings have indicated 
that the reliability for the M5-120 is in the acceptable range with an average Cronbach’s 
alpha of .68 (Johnson, 2001), internal consistency was good in the current sample, α = 
.80. 
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Emotional expression recognition. To register eye movements, the present study 
utilized the Tobii TX 300 Eye Tracker. Pictures from the Ekman series of basic 
emotional expressions were used in a facial expression recognition task (Ekman, 1993). 
The task required participants to view 34 randomized pictures of happy, sad, angry, 
disgusted, and neutral faces, 14 male and 14 female. First, a ten-point calibration, (i.e., 
five points per eye) was performed for each participant prior to the task. Next, the 
participant received the directions on the screen, along with verbal instructions. The task 
required participants to press a corresponding key on the computer, indicating whether 
they saw a positive, negative, or neutral facial expr ssion, (by pressing ‘f’, ‘j’, or space 
bar, respectively). Each picture appeared on the screen until the participant pressed the 
answer key. After the first five pictures, the participants were given a reminder to ensure 
that they pressed the correct key for their intended responses. 
Accuracy scores were created based on whether or not the participant pressed the 
correct key identifying positive, negative, or neutral affect. Next, these scores were 
converted into accuracy percentages for each type of em tion, (e.g., happy, sad, disgust, 
angry, and neutral). In addition to correct responses, gaze durations on areas of interest 
within a face were categorized by emotion and summed. Specifically, these areas 
included the eyes and mouth. 
The lateralization preference of each participant was determined by summing the 
total visit duration (i.e., total time including fixations and saccades) for the left and right 
sides of every picture. While previous studies have calculated lateralization preference 
based on the direction of the first saccade, (Leonards & Mohr, 2009), other research 
suggests that this marker may only be indicative of a visual preference in schizophrenia, 
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as this population has problems shifting visual attention to different facial hemispheres 
after the initial fixation (Phillips & David, 1997). Because the current sample consists of 
college students, the total visit duration of left and right facial hemisphere may be more 
useful in determining lateralization preference.   
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CHAPTER FOUR: RESULTS 
Self-Report Results 
Normality testing. Exploratory analyses were conducted to examine the 
distribution of the data. Cannabis use frequency was not normally distributed (skewness 
= 1.92, SE = .16, kurtosis = 2.57, SE = .31). The dichotomous grouping of cannabis users 
of the last 6 months, (i.e., no use versus use) was non-normally distributed, (skewness = 
.86, SE = 0.16, kurtosis = -1.27, SE = .31), as was the problematic cannabis use, 
(skewness = 2.19, SE = .16, kurtosis = 4.20, SE = .31). Additional analyses were 
conducted, and the results of a series of Kolmogorov-Smirnova Tests of Normality 
verified this non-normal distribution. Additionally, two schizotypy variables were 
significant, which indicates non-normality: disorganized schizotypy (D = .071, df = 241, 
p < .01) and negative schizotypy (D = .116, df = 241, p < .01). Because the cannabis 
variables and two schizotypy variables are not normally distributed, non-parametric tests 
were chosen to analyze the data (Pallant, 2010). 
Descriptive statistics. Of the total sample, 169 (69.8%) participants had not used 
cannabis in the last 6 months. Seventy-three (30.2%) participants in the sample had used 
cannabis in the last 6 months, which is consistent with literature citing a 33% prevalence 
rate of cannabis use among college students within the past year (Johnston et al., 2011). 
Cannabis use frequency can be seen in the following (Table 2). For descriptive statistics 
for schizotypy factors and total, as well as personality domains, please see Table 3.  
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Table 2.  
Cannabis Use Frequency of the Total Sample  
___________________________________________________________________ 
Cannabis Use Frequency                                      n              Percent                                  
Never                                                                               169           69.8%                                              
Monthly or Less                                                                 36           14.9% 
2-4 Times a Month                                                            12             5.0% 
2-3 Times a Week                                                             10             4.1% 
4 or More Times a Week                                                   15             6.2% 
___________________________________________________________________ 
N = 242 
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Table 3.  
Descriptive Statistics for Schizotypal Personality Questionnaire-Brief Revised (SPQ-BR) 
Total and Factors and M-5 Personality Domains 
___________________________________________________________________ 
   Characteristic                                  Median               Minimum            Maximu 
Total Schizotypy*                                  73.00                     34.00                118.00 
Positive Schizotypy                                   34.00                     16.00                 58.00 
Disorganized Schizotypy*                         25.00                       8.00                   40.00 
Negative Schizotypy*                     13.00                       6.00                    29.00 
Extraversion                                               53.31                     25.67              70.42             
Agreeableness           54.66                      27.18                   73.23 
Conscientiousness          54.26                      33.46                   73.70 
Neuroticism                       45.76                      23.62                   71.77 
Openness to Experience         43.66               17.45                   67.21 
___________________________________________________________________ 
N = 242, *N = 241 
Cannabis Use and Schizotypy 
Mann-Whitney U tests. To test the first hypothesis, a series of Mann-Whitney U 
Tests were conducted with a Bonferroni correction (.e., .05 divided by 4) of .0125. 
Results revealed no significant differences in negative schizotypy between individuals 
who did not use cannabis in the last 6 months, (Md = 13.00, n = 168) and those who used 
cannabis in the last 6 months, (Md = 14.00, n = 73), U = 5590.00, z = -1.09, p > .05. 
There was also no significant difference in positive schizotypy, with cannabis users in the 
last 6 months (Md = 35.00, n = 73) and non-users in the last 6 months, (Md = 34.00, n = 
169), U = 5331.00, z = -1.68, p > .05. A significant difference in disorganized schizotypy 
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was found between non-users of cannabis in the last 6 months, (Md = 24.00, n = 168) 
compared to users of cannabis (Md = 28.00, n = 73), U = 4869.00, z = -2.54, p = .01, r = 
.16. There was also a marginally significant difference in total schizotypy, with cannabis 
users in the last 6 months (Md = 76.00, n = 73) and non-users in the last 6 months, (Md = 
71.30, n = 168), U = 5037.00, z = -2.20, p < .05, r = .14. Overall, users of cannabis in the 
last 6 months had significantly higher disorganized schizotypy and marginally higher 
total schizotypy scores compared to non-users. Thus, t e first hypothesis was partially 
supported.  
Correlations. A bivariate correlation matrix was analyzed to test hypothesis two 
and determine associations between schizotypy total and subscale scores, frequency of 
cannabis use, and cannabis-related problems. As expected, there was a significant 
positive correlation between cannabis use frequency a d cannabis-related problems, 
r(242) = .739, p < .001. Consistent with hypothesis two, all schizotypy factors were 
significantly associated with cannabis-related problems in the positive direction; 
however, only disorganized and total schizotypy were significantly correlated to cannabis 
use frequency. The whole sample was used because nine participants who did not use 
cannabis in the last 6 months reported cannabis-related problems. If participants refrained 
from use due to these issues, this data is relevant to the current study.  
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Table 4.  
Correlations between Schizotypy, Cannabis Use Frequency, and Cannabis-Related 
Problems 
Schizotypy 
Cannabis 
Use 
Frequency 
Cannabis-
Related 
Problems 
Total (N = 241) r = .154* r = .201** 
Positive (N = 242) r = .119 r = .156* 
Disorganized (N = 241) r = .157* r = .168** 
Negative (N = 241) r = .073 r = .141* 
                           *p < .05, **p < .01 
Cannabis Use and Personality 
Mann-Whitney U tests. Next, the third hypothesis was tested with a serie of 
Mann-Whitney U Tests, calculated to assess for significa t differences between users 
versus non-users in personality domains. A Bonferroni c rrection of 5 was applied. As 
can be seen from Table 5, only Agreeableness, (U = 3907.00, r = .29) and 
Conscientiousness, (U = 4135.50, r = .27) were significantly different, with users of 
cannabis in the last 6 months scoring lower in both domains. There were no significant 
differences in Neuroticism, Extraversion, and Openness to Experience between users and 
non-users of cannabis in the last 6 months. While hypothesis three was correct in that 
users of cannabis were lower in Agreeableness and Co scientiousness, they were not 
higher in Openness to Experience or the Neuroticism facets of Anger and Vulnerability, 
as predicted; however, cannabis users were higher in Immoderation, consistent with 
hypothesis three.  
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Table 5.  
Medians, U-Statistics, and Z-Scores for Personality Domain Comparisons between Non-
Cannabis and Cannabis Users of the Last 6Months 
___________________________________________________________________ 
                          No Cannabis Use        Cannabis Use      Mann-Whitney 
Statistics 
    (n = 168)                   (n = 74)  
Personality Domains        Md                 Md                 U                     z          
Neuroticism                45.76     46.17        564 .00            0.26 
 
Extraversion     53.31     53.97       5729.00       0.33 
 
Agreeableness                55.40     49.49             3917.00           -4.58* 
  
Conscientiousness               55.97     51.19          4122.50           -4.17* 
 
Openness to Experience           42.33          44.74              5645.00           -1.20 
___________________________________________________________________ 
*p < .01 
 
 Because Agreeableness and Conscientiousness were significantly lower in 
cannabis users, another series of Mann-Whitney U Tests were conducted to examine 
facet-level differences within these domains between cannabis and non-cannabis users. 
Results can be seen in Table 6. A Bonferroni correction of .004 was set to control Type I 
error inflation. Compared to non-users, cannabis users in the last 6 months were lower in 
Trust, Tendermindedness, Cooperation, Dutifulness, Achievement-Striving, Self-
Discipline, and Cautiousness. These results partially support the third hypothesis, which 
predicted that cannabis users would be lower in all facets of Conscientiousness and 
Agreeableness, although only the aforementioned facets were significantly lower in 
cannabis users in this sample.                             
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Table 6. 
 
Medians, U-Statistics, and Z-Scores for Personality Facet Comparisons between Non-
Cannabis and Cannabis Users of the Last 6Months 
___________________________________________________________________ 
    No Cannabis Use         Cannabis Use     Mann-Whitney Statistics     
              (n = 169)                     (n = 73)  
Personality Facets                 Md      Md                  U               z 
Trust (A1)                          54.73       49.3                    4374.00      -3.61* 
 
Morality (A2)               51.57        48.32            4921.50      -2.52 
 
Altruism (A3)               53.57         52.40               5196.00      -1.97 
 
Cooperation (A4)              55.82     50.74         4681.00      -2.99* 
 
Modesty (A5)               51.96          51.07                5615.50      -1.11 
Tendermindedness (A6)          56.17                     49.84                    4575.50      -3.21* 
Self-Efficacy (C1)         55.00                       50.92                    5080.50      -2.21 
 
Order (C2)                               56.73                      54.46                    5163.00      -2.02 
 
Dutifulness (C3)                      57.28                           49.99                    4486.00      -3.40* 
 
Achievement-Striving (C4)     54.63                           51.69                    4767.00      -2.82* 
 
Self-Discipline (C5)                55.44                       52.40                   4486.50      -3.38* 
 
Cautiousness (C6)                   52.86                     45.64                   4312.00      -3.72* 
__________________________________________________________________ 
*p < .004 
 
Correlations. To complete testing of the third hypothesis, bivariate correlations 
were calculated between personality and cannabis use frequency. Additional correlations 
were conducted between personality and cannabis-related problems to address the first 
research question. Results can be seen in the following table. Overall, Immoderation, 
Gregariousness, and Excitement-Seeking were positively associated to cannabis use 
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frequency and cannabis-related problems. Cannabis use and related problems were also 
associated with lower Emotionality, Agreeableness, Trust, Altruism, Cooperation, 
Tendermindedness, Order, Dutifulness, Achievement-Striving, Self-Discipline, and 
Cautiousness.  Low Activity was only correlated with cannabis use frequency, while low 
Morality was only correlated with cannabis-related problems.   
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Table 7. 
Correlations between Personality Domains, Facets, Cannabis Use Frequency, and 
Cannabis-Related Problems 
Domains and Facets 
Cannabis 
Use 
Frequency 
Cannabis-
Related 
Problems 
(N = 242) (N = 242) 
Neuroticism r = .057 r = .059 
Anxiety r = .003 r = -.035 
Anger r = .110 r = .117 
Depression r = -.006 r = .067 
Self-Consciousness r = -.074 r = -.113 
Immoderation r = .218** r = .242** 
Vulnerability r = .002 r = -.014 
Extraversion r = .100 r = .081 
Friendliness r = -.040 r = -.027 
Gregariousness r = .211** r = .156* 
Assertiveness r = .029 r = .010 
Activity r = -.134* r = -.068 
Excitement-Seeking r = .245** r = .241** 
Cheerfulness r = .027 r = -.041 
Openness to Experience r = .045 r = .091 
Imagination r = .085 r = .066 
Artistic Interests r = .044 r = .108 
Emotionality r = -.146* r = -.133* 
Adventurousness r = .049 r = .095 
Intellect r = .024 r = .062 
Liberalism r = .081 r = .109 
Agreeableness r = -.249** r = -.302** 
Trust r = -.294** r  = -.255** 
Morality r = -.121 r = -.225** 
Altruism r = -.129* r = -.175** 
Cooperati  on r = -.168* r = -.231** 
Modesty r = -.035 r = -.077 
Tendermindedness r = -.195** r = -.207** 
Conscientiousness r = -.262** r= -.288** 
Self-Efficacy r = -.068 r = -.041 
Order r = -.131* r = -.183** 
Dutifulness r = -.307** r = -.340** 
Achievement-Striving r = -.145* r = -.205** 
Self-Discipline r = -.229** r = -.214** 
Cautiousness r = -.222** r = -.221** 
            *p < .05, **p < .01 
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Schizotypy and Personality 
Correlations. To assess the fourth hypothesis, bivariate correlations were 
calculated between personality and schizotypy score. Hypothesis four was partially 
supported, with all schizotypy scales significantly positively associated with Neuroticism, 
and all schizotypy scales were negatively correlated with Conscientiousness, as predicted. 
Further, all factors of schizotypy were significantly negatively associated with 
Extraversion and Agreeableness except disorganized schizotypy. While positive and 
disorganized schizotypy were positive association with Openness to Experience as 
hypothesized, negative schizotypy was not significantly negatively associated with 
Openness to Experience. Hypothesis four was correct in that all facet-level correlations 
between schizotypy factors and Neuroticism were significantly associated, although 
negative schizotypy was not associated with Immoderation. All facets of 
Conscientiousness were also negatively associated wi h all factors of schizotypy as 
predicted, with the exception of associations betwen negative schizotypy, Order, and 
Cautiousness. Associations with the facets of Extraversion, Agreeableness, and Openness 
to Experience vary by schizotypy factor. For all domain- and facet-level results, see 
Table 8. 
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Table 8. 
Correlations between Personality Domains, Facets, Total Schizotypy, and Schizotypy 
Factors 
Domains and Facets 
Total 
Schizotypy 
Positive 
Schizotypy 
Disorganized 
Schizotypy 
Negative 
Schizotypy 
  (N = 241) (N = 242) (N = 241) (N = 241) 
Neuroticism r = .503** r = .484** r = .323** r = .321** 
Anxiety r = .361** r = .368** r = .240** r = .187** 
Anger r = .317** r = .315** r = .223** r = .162* 
Depression r = .473** r = .422** r = .248** r = .431** 
Self-Consciousness r = .306** r = .207** r = .200** r = .342** 
Immoderation r = .345** r = .388** r = .264** r = .071 
Vulnerability r = .374** r = .390** r = .228** r = .205** 
Extraversion r = -.242**  r = -.134* r = -.093 r = -.409** 
Friendliness r = -.478** r = -.333** r = -.244** r = -.608** 
Gregariousness r = -.114 r = -.008 r = -.072 r = -.253** 
Assertiveness r = -.140* r = -.106 r = -.095 r = -.131* 
Activity r = -.098 r = -.044 r = -.062 r = -.150* 
Excitement-Seeking r = .161* r = .159* r = .214** r = -.049 
Cheerfulness r = -.329** r = -.236** r = -.108 r = -.486** 
Openness to Experience r = .185** r = .130* r = .238** r = .046 
Imagination r = .330** r = .266** r = .328** r = .147* 
Artistic Interests r = .126 r = .075 r = .158* r = .057 
Emotionality r = .006 r = .074 r = .090 r = -.225** 
Adventurousness r = -.011 r = -.007 r = .075 r = -.050 
Intellect r = -.079 r = -.124 r = -.008 r = -.023 
Liberalism r = .251** r = .184** r = .206** r = .202** 
Agreeableness r = -.361** r = -.355** r = -.122 r = -.357** 
Trust r = -.381** r = -.302** r = -.152* r = -.478** 
Morality r = -.275** r = -.298** r = -.097 r = -.219** 
Altruism r = -.249** r = -.226** r = -.079 r = -.288** 
Cooperation r = -.334** r = -.334** r = -.178** r = -.235** 
Modesty r = .022 r = -.037 r = -.074 r = .042 
Tendermindedness r = -.175** r = -.188** r = -.031 r = -.184** 
Conscientiousness r = -.477** r= -.400** r = -.399** r = -.284 
Self-Efficacy r = -.365** r = -.301** r = -.262** r = -.285** 
Order r = -.239** r = -.215** r = -.215** r = -.095 
Dutifulness r = -.331** r = -.315** r = -.221** r = -.209** 
Achievement-Striving r = -.332** r = -.276** r = -.216** r = -.283** 
Self-Discipline r = -.389** r = -.259** r = -.377** r = -.286** 
Cautiousness r = -.365** r = -.330** r = -.351** r = -.114 
*p < .05, **p < .01  
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Cannabis-Related Problems 
While the first research question sought to find signif cant predictors of cannabis-
related problems, this could not be examined with this dataset. Despite recoding and 
transforming the data to reduce skewness and kurtosis in the cannabis-related problems 
variable, no transformation reduced skewness and kurtosis to acceptable levels. Every 
viable suggestion from multiple sources (Field, 2005, pp. 153-155; Pallant, 2010, p. 93) 
was used in an attempt to transform the data. Becaus  the outcome variable is not 
normally distributed, a regression would not be appro riate, and non-parametric options 
were then explored. When using the PUM as an indicator of cannabis-related problems, 
the cutoff score of 2 for ICD-10 dependence classification has 80.9% sensitivity 
(Okulicz-Kozaryn, 2007). Based on this information, the sample was divided into three 
categories: 1.) Zero (0) or no cannabis-related problems, 2.) One to two cannabis-related 
problems, and 3.) Three or more cannabis-related problems, with each category 
representing the total PUM score.   
Cannabis-Related Problems and Schizotypy 
Kruskal-Wallis test. In order to find differences in schizotypy as a function of 
cannabis-related problems, a Kruskal-Wallis Test was conducted. While there were no 
significant differences in positive schizotypy, there was a statistically significant 
difference across groups within disorganized, χ2 = 7.46, p < .05, negative, χ2 = 7.08, p < 
.05, and total schizotypy, χ2 = 9.85, p < .01. A series of nonparametric Mann-Whitney U 
Tests post-hoc analyses at the Bonferroni adjusted level (i.e., .05 divided by 12) of .004 
indicated no differences in schizotypy between those with one or two problems and those 
with three or more problems. When compared to those with no problems, individuals 
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with one to two problems endorsed more negative, U = 2459.00, z = -2.47, p = .01, r = 
.17 and total schizotypy, U = 2422.00, z = -2.57, p = .01, r = .17, although these 
differences were only marginally significant. Descriptive statistics for each group can be 
found in the following table. Again, disorganized, negative, and total schizotypy was 
significantly different among cannabis-related problems groups, and this appears to be 
driven by differences in disorganized schizotypy between those who have any cannabis-
related problems versus those with no cannabis-related problems, as well as the 
subclinical group’s higher negative schizotypy scores. 
Table 9. 
Median Schizotypy Scores across Cannabis-Related Problems Groups 
__________________________________________________________________ 
                                                                                      Cannabis-Related Problems Groups 
 
Schizotypy                   No Problems        1-2 Problems     3+ Problems 
          (n = 179)                (n = 34)          (n = 25) 
 
Total Schizotypy                                   71.00*               78.00                77.00      
Positive Schizotypy                            33.00                 36.00               35.60 
Disorganized Schizotypy                            24.00                 28.00                29.00 
Negative Schizotypy                                          13.00                 15.00              14.00       
__________________________________________________________________ 
*n = 180 
Cannabis-Related Problems and Personality 
Kruskal-Wallis test. Next, another Kruskal-Wallis Test was analyzed for 
differences in personality across cannabis problem groups. Only Agreeableness, χ2 = 
23.33, p < .001, and Conscientiousness, χ2 = 23.67, p < .001, were significantly different 
across groups. A Kruskal-Wallis Test was also conducted to assess facet-level personality 
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differences across cannabis problem groups. The following facets were significantly 
different: Excitement-Seeking, χ2 = 17.89, p < .001, Trust, χ2 = 15.20, p < .001, Morality, 
χ
2 = 10.78, p < .01, Cooperation, χ2 = 14.04, p = .001, Tendermindedness, χ2 = 8.86, p < 
.05, Self-Efficacy, χ2 = 7.37, p < .05, Order, χ2 = 9.90, p < .01, Dutifulness, χ2 = 20.434, p 
< .001, Achievement-Striving, χ2 = 16.59, p < .001, Self-Discipline, χ2 = 10.54, p < .01, 
Cautiousness, χ2 = 16.13, p < .001, Anger, χ2 = 6.17, p < .05, and Immoderation, χ2 = 
12.41, p < .01. 
 Mann-Whitney U tests of personality domains. Post-hoc analyses consisted of 
a series of Mann-Whitney U Tests. For the two domains of interest, a Bonferroni 
correction was applied, (i.e., 05 divided by 6) of .008. Agreeableness was significantly 
different between those with no cannabis-related problems (Md = 55.40) and those with 
1-2 cannabis-related problems, (Md = 49.46), U = 2192.50, z = -3.27, p = .001, r = 0.22. 
This difference was also found between the no-problem group (Md = 55.40) and the 3 or 
more problem group (Md = 49.46), U = 1138.50, z = -4.00, p < .001, r = 0.28. There were 
no differences between the 1-2 and 3+ cannabis-related problems groups, U = 407.50, z = 
-0.79, p > .05. Conscientiousness was also significantly different between the no 
cannabis-related problems group (Md = 55.63) and those with 1-2 cannabis-related 
problems, (Md = 50.51), U = 2206.50, z = -3.23, p = .001, r = 0.22. This difference was 
even more pronounced between the no-problem group (Md = 55.63) and the 3 or more 
problem group (Md = 47.37), U = 1143.50, z = -3.98, p < .001, r = 0.28. No differences 
were observed between the 1-2 problems groups (Md = 55.63) and the 3+ group (Md = 
47.37), U = 368.00, z = -1.36, p > .05. In sum, Agreeableness and Conscientiousness 
were higher in individuals with no cannabis-related problems. 
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 Mann-Whitney U tests of personality facets. Another series of Mann-Whitney 
U Tests were then conducted post-hoc with a Bonferroni correction (i.e., .05/39) .001 to 
test for group differences in significant personality facets previously reported. Results can 
be seen in Table 10, while the medians of the facets of interest for each group are listed in 
Table 11. The data suggests that when compared to in ividuals who do not experience 
cannabis-related problems, those who meet criteria fo  cannabis dependence (i.e, three or 
more cannabis-related problems), are significantly higher in Excitement-Seeking, 
marginally higher in Immoderation, and significantly lower in Cooperation, Dutifulness, 
and Cautiousness. Interestingly, those with one or tw  cannabis-related problems were 
significantly lower in Trust and Achievement-Striving when compared to those with no 
problems.  
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Table 10.  
Mann-Whitney U Statistics for Facet-Level Personality Differences across Cannabis-
Related Problems Groups (With Z Statistic in Parenth ses)  
___________________________________________________________________ 
                                                  
             Group Comparisons                            Effect Size 
     
Personality Facets              0 v 1-2               0 v 3+                 1-2 v 3+             r 
Excitement- Seeking (E5)    2424.00(-2.62)     1252.00(-3.61)*    342.50(-1.74)           *0.25  
 
Trust (A1)                      2134.50(-3.45)*   1613.50(-2.30)      443.50(-0.27)        *0.23 
 
Morality (A2)           2617.00(-2.07)      1470.00(-2.83)      409.00(-0.77)        
 
Cooperation (A4)          2578.00(-2.18)      1332.50(-3.32)*    370.50(-1.33)       *0.23 
 
Tendermindedness (A6)      2825.50(-1.46)     1474.00(-2.81)      393.00(-1.01)       
Self-Efficacy (C1)               2395.50(-2.72)     2221.50(-0.10)      347.50(-1.69)       
 
Order (C2)                           2845.00(-1.40)      1424.00(-2.99)      359.50(-1.48)       
 
Dutifulness (C3)                  2740.50(-1.72)     1056.00(-4.34)*    280.50(-2.64)        *0.30  
 
Achievement-Striving (C4) 2207.50(-3.25)*   1449.50(-2.90)      452.00(-0.15)        *0.22 
 
Self-Discipline (C5)            2709.00(-1.80)     1443.50(-2.92)      372.50(-1.30)       
 
Cautiousness (C6)               2411.00(-2.65)     1321.50(-3.35)*    385.00(-1.12)        *0.23 
 
Anger (N2)                     2496.00(-2.41)      1971.50(-1.01)      414.50(-0.69)       
 
Immoderation (N5)             2657.00(-1.95)     1375.00(-3.16)      362.50(-1.44)       
___________________________________________________________________ 
*p < .001 
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Table 11. 
 
Median Facet Scores across Cannabis-Related Problems Groups 
__________________________________________________________________ 
                                              
           Number of Problems 
 
         None                   1-2                   3+                                
       (n = 180)           (n = 37)            (n = 25)  
Personality Facets                        Md                     Md                   Md                        
Excitement-Seeking (E5)                47.39                 51.51               54.26 
 
Trust (A1)                                 54.73              46.72           52.06       
 
Morality (A2)                      51.57            51.57           45.08       
 
Cooperation (A4)                     55.82         50.74           48.20       
 
Tendermindedness (A6)                 54.59           53.00             46.68       
Self-Efficacy (C1)                          50.92                50.92               50.92       
 
Order (C2)                                      56.73                 54.46               52.19       
 
Dutifulness (C3)                             57.28                  53.64               46.35       
 
Achievement-Striving (C4)            54.63                 48.75               48.75       
 
Self-Discipline (C5)                       55.44              52.40               52.40       
 
Cautiousness (C6)                          52.86                 45.64               45.64       
 
Anger (N2)                                44.48                  49.16        46.04       
 
Immoderation (N5)                        43.52             46.36            49.20     
___________________________________________________________________  
Eye Tracker Results 
Descriptive statistics. Within the eye-tracker sample (N = 70), 49 participants 
(70.0%) had not used cannabis in the last 6 months, w ile 21 participants (30.0%) had 
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used cannabis. Descriptive statistics of cannabis use frequency can be seen in the next 
table. Table 13 lists descriptive statistics of schizotypy scores and personality domains. 
Table 12. 
Cannabis Use Frequency of the Eye Tracker Sample 
___________________________________________________________________ 
Cannabis Use Frequency                                     n                  Percent  
Never                                                                                       49             70.0%                                                 
Monthly or Less                                                                 10               14.3% 
2-4 Times a Month                                                             4                 5.7% 
2-3 Times a Week                                                              2                 2.9% 
4 or More Times a Week                                                   5                     7.1% 
___________________________________________________________________ 
N = 70 
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Table 13.  
Descriptive Statistics for Schizotypal Personality Questionnaire-Brief Revised (SPQ-BR)  
Total and Factors and M-5 Personality Domains 
___________________________________________________________________ 
Characteristic                                           Median                  Minimum            Maximum 
Total Schizotypy*                                  73.00                       45.00              118.00 
Positive Schizotypy                                   35.00                       18.00               56.00 
Disorganized Schizotypy*                         24.00                       12.00                    40.00 
Negative Schizotypy*                               13.00                         6.00                24.00 
Extraversion                                               55.61                       30.93              67.13             
Agreeableness                      53.92                 32.38                    72.49 
Conscientiousness          52.90                        34.82                    73.70 
Neuroticism                       44.95                        25.45                    69.33 
Openness to Experience         43.54                19.86                    64.00 
___________________________________________________________________ 
N = 70 
To examine associations between emotion recognition accuracy and the variables 
of interest,  a bivariate correlation was calculated with schizotypy (positive, disorganized, 
negative, and total), frequency of cannabis use, cannabis-related problems, personality, 
total feature fixation duration and fixation counts for eyes and mouths of each type of 
emotion, and emotion recognition accuracy. Accuracy for each emotion, along with the 
fixation duration and fixation count for the eyes and mouth of each type of emotion, were 
analyzed in a bivariate correlation matrix with total and subscales of schizotypy, 
frequency and problematic cannabis use, and personality domains and facets.  
 
57 
 
 
Emotion Identification Accuracy 
Correlations. The correlational results suggest that total, positive, and 
disorganized, but not negative schizotypy, are associated with a reduced ability to 
identify neutral; conversely, individuals higher in these characteristics were associated 
with an increased ability to identify happy faces. Excitement-Seeking correlates to 
inaccuracy in identifying emotions overall, but sad f ces in particular.  Accuracy for 
identifying all faces was also negatively correlated with Self-Efficacy, r(70) = .242, p < 
.05, and Cautiousness, r(70) = .306, p = .01. Additionally, accuracy in identifying neutral 
faces was positively associated with Conscientiousnes , r(70) = .307, p = .01, as well as 
the Conscientiousness facets of Self-Efficacy, r(70) = .331, p < .01, Self-Discipline, r(70) 
= .360, p < .01, and Cautiousness, r(70) = .302, p = .01. Immoderation was marginally 
negatively associated with accuracy for identifying neutral faces, r(70) = -.233, p = .05.  
 With regard to negative emotions, accuracy in identifyi g sad faces was 
negatively associated with Excitement-Seeking, r(70) = -.236, and p < .05, Cheerfulness, 
r(70) = -.250, p < .05. Positive associations with accuracy for sad faces include Anxiety, 
r(70), .239, p < .05, and Intellect, r(70) = .330, p < .01. Disgust accuracy was positively 
correlated to Trust, r(70) = .245, p < .05, and negatively correlated with Liberalism, r(70) 
= -.263, p < .05. Identifying angry faces correctly was positively associated with Trust, 
r(70) = .263, p < .05. For all emotional identification accuracy correlations, refer to 
Appendix I. It should also be noted that emotional identification accuracy was not 
associated with cannabis use frequency or cannabis-related problems. 
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Feature Fixation  
Correlations. Cannabis-related problems were negatively associated with fixation 
duration of happy eyes, r(70) = -.250, p < .05, and fixation count for happy eyes, r(70) = 
-.252, p < .05. Fixation count for neutral eyes was negatively associated with cannabis-
related problems, r(70) = -.266, p < .05, as well as marginally negatively correlated with 
Extraversion, r(70) = -.231, p = .05. For neutral mouths, total fixation count was 
positively associated with disorganized schizotypy, r(70) = .249, p < .05, and negatively 
correlated with Conscientiousness, r(70) = -.258, p < .05. For sad eyes, cannabis-related 
problems were negatively associated with fixation cunt, r(70) = -.247, p < .05. For sad 
mouths, disorganized schizotypy was positively correlated with total fixation duration, 
r(70) = .259, p < .05.  
Extraversion was negatively correlated with the total fixation duration on angry 
eyes r(70) = -.251, p < .05, and fixation count for angry eyes, r(70) = -.299, p = .01. 
Moreover, total fixation duration for angry mouths was significantly positive associated 
with disorganized schizotypy, r(70) =.258, p < .05, and cannabis-related problems, r(70) 
= .243, p < .05; however, this associated was negative for fixation on angry mouths and 
Conscientiousness, r(70) = -.277, p < .05. Cannabis-related problems were negatively 
associated with fixation duration, r(70) = -.255, p < .05, as well as fixation count, r(70) -
.252, p < .05, for eyes of disgusted faces. Conversely, total fixation duration on disgust 
mouths was positively correlated with disorganized schizotypy, r(70) = .274, p < .05. All 
fixation associations, including personality facet orrelations, can be found in Appendix 
K. In sum, as the number of cannabis-related problems increased, focus on happy, 
neutral, disgust, and sad eyes decreased, although attention to angry mouths increased. 
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Disorganized schizotypy was positively associated with fixation on angry, sad, disgust, 
and neutral, but not happy, mouths. 
Lateralization  
Unexpectedly, schizotypy was not associated with the total visit duration of the 
left or right side. However, cannabis use frequency was negatively correlated with visit 
duration of left lateralization. While no personality domains were correlated to lateralized 
visit duration, the Agreeableness facet of Altruism, r(70) = -.296, p = .01, and the 
Openness facet of Feelings, r(70) = -.374, p < .01, were negatively associated with the 
total visit duration of the right side of emotional f ces. All lateralization correlations can 
be found in Appendix J. Next, a chi square test of independence was conducted between 
cannabis use in the last 6 months and lateralization preference. There was a marginally 
significant association between cannabis use in the last 6 months and right lateralization 
preference, χ2 (1, N = 70) = 3.053, p = .08, phi = -.209.  
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CHAPTER FIVE: DISCUSSION 
Within the last 6 months, 30.2% of the total sample and 30.0% of the eye tracker 
subsample used cannabis. These rates are similar to those in Johnston and colleagues’ 
findings (2011), which examined substance use habits of college students and adults ages 
19-50 and found a cannabis prevalence rate of 33% on college campuses and 32% in 
noncollege young adults. Further, daily cannabis use is reported by between 4.4% 
(college students) and 7.7% (noncollege individuals) in previous research (e.g., Johnston 
et al., 2011). Although daily use was not assessed in the current study, 6.2% of the total 
sample and 7.1% of the eye tracker subsample endorsed using cannabis four or more 
times a week. Given this high rate of frequent use,th se results may be generalizable to 
emerging adulthood and not necessarily restricted to college settings.  
Cannabis Use and Schizotypy 
Consistent with previous literature (Barkus & Lewis, 2008; Schiffman et al., 
2005) and partially supporting the first hypothesis, d organized schizotypy scores were 
higher for cannabis users of the last 6 months relativ  to non-users. Although positive 
symptoms were only marginally higher in cannabis users than non-users, this difference 
was significant before controlling for Type I error inflation, suggesting that this 
difference might be significant with a larger sample. For example, Cohen and associates 
(2011) found that frequent cannabis use was associated with more positive and 
disorganized schizotypy traits, regardless of whether or not the individual met the clinical 
cutoff for schizotypy. This corroborates the dopamine hypothesis in that cannabis, a 
dopaminergic agonist, increases the psychosis-prone t aits in individuals, although this is 
not specific to those at a higher risk for later schizophrenia-spectrum disorders. In other 
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words, the significantly higher disorganized and marginally higher cognitive schizotypy 
scores in this sample may be a function of the effects of cannabis use, rather than a 
genetic predisposition for schizophrenia-spectrum disor ers. Illicitly distributed cannabis 
is now lower in cannabidiol and higher in ∆9-THC, which could more easily potentiate 
anxiogenic and psychotic symptoms (Potter, Clark, & Brown, 2008). More research 
needs to be on schizotypy and cannabis use, as these associations are still largely 
unexplained. 
 The significant association between cannabis use frequency and disorganized 
schizotypy may be artificially inflated. Previous work (Earlywine, 2006; Esterberg et al., 
2009) has shown that substance users may misinterpre  certain items on the SPQ-B, and 
SPQ-BR (e.g., “I sometimes use words in unusual ways”; “Other people see me as 
slightly eccentric [odd]”; and “People sometimes comment on my unusual mannerisms 
and habits”). While the first item was removed in the creation of the SPQ-BR, the second 
and third items are within the Eccentric Behavior subscale of disorganized schizotypy on 
the SPQ-BR. Interestingly, cannabis users had significa tly higher scores on these items 
when compared to non-users within this sample (data not shown). Because this has also 
been observed in alcohol users, substance users in general may be perceived as different 
or unconventional, and these individuals may label th mselves as such from 
interpretations of social interactions (Esterberg et al., 2009).  
The other subscale comprising disorganized schizotypy is Odd Speech, on which 
are two items that cannabis users scored higher on in this sample: “Do you tend to 
wander off the topic when having a conversation?” and “I sometimes forget what I am 
trying to say.” These items reflect loose associations and short-term memory deficits, 
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both of which are symptomatic of cannabis use, regardless of psychosis-proneness. 
Further, Barkus and Lewis (2008) noted higher disorganized schizotypy scores in current 
versus former cannabis users, as well as those who had used cannabis at least  once 
versus never. Taken together, these data suggest that the higher disorganized schizotypy 
scores in cannabis users of the last 6 months, as well as the association between cannabis 
use frequency and disorganized schioztypy, are artificially inflated by item functioning 
and physiological effects of immediate cannabis use, rather than an increase in the risk 
for psychosis. 
Unlike the findings of Skosnik and researchers (2008), the negative schizotypy 
scores of cannabis users were not significantly different from non-users in this study, 
which contradicts the self-medication model and the notion that individuals with less 
negative schizotypal traits are more likely to use substances (Potvin, Sepehry, & Stip, 
2006). It is possible that because the majority of the cannabis users only used cannabis 
approximated once a month, this is not representative of the more frequent cannabis user, 
who may experience less negative schizotypy symptoms. Another plausible explanation 
is that negative schizotypy traits are only ameliorated in individuals who are clinically 
schizotypal. This hypothesis would explain the why cannabis use frequency was not 
significantly associated with negative symptoms in th s sample and is consistent with 
previous research findings of lower negative schizotypy scores with cannabis use only in 
individuals with clinically elevated levels of schizotypy (Cohen et al., 2011). Regardless 
of the cause, the results of the current study suggest that cannabis use does not decrease 
negative schizotypal symptoms in college students, al hough there was a trend suggesting 
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that negative schizotypal symptoms are lowered in indiv duals with more cannabis-
related problems.   
Like frequency of cannabis use, related problems were most closely associated 
with disorganized schizotypy. Unlike frequency, which was only significantly associated 
with disorganized and total schizotypy, cannabis-related problems were significantly 
correlated to all schizotypy factors, as well as the total; however, it should be noted that 
these correlations were weak (i.e., r < .25). Despite this, the data trend suggests that there 
is something unique about the association between can abis-related problems and 
schizotypy not captured by cannabis use alone. It may be that those experiencing 
cannabis-related problems are more likely to also experience schizotypal symptoms, with 
an underlying predisposition toward general psychopathology and impairment in 
functioning. While this perspective seems congruent with the supersensitivity hypothesis, 
it may not be that cannabis use and related problems increase the vulnerability for 
schizophrenia-spectrum disorders.  
Cannabis Use and Personality 
Contrary to hypothesis three, cannabis use was not associated with Openness to 
Experience. Only the facet of Emotionality was associated with cannabis use frequency 
and related problems. These inverse associations sugge t that cannabis users may have 
slightly blunted affect and may not consider emotions to be of high importance. While 
the finding that Neuroticism was not significantly related to cannabis use frequency is 
consistent with research by Terracciano and research rs (2008), the current findings are 
different in that only the facet of Immoderation was positively associated with cannabis 
use, not Anger or Vulnerability. This discrepancy may be due to the ages of participants, 
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as this sample was comprised of college students, while Terracciano and colleagues 
(2008) had participants who ranged from 30 to 94 years old. The association with 
Immoderation was stronger for cannabis-related problems. Higher impulsivity may lead 
to trouble controlling cannabis use frequency, as well as adhering to social 
responsibilities, such as school or work. This finding of trait impulsivity is consistent 
with previous conceptualizations of individuals who use substances (Bardo, Kelly, 
Lynam, & Milich, 2006). 
 Although no hypothesis was made regarding cannabis use and Extraversion, 
Gregariousness and Excitement-Seeking were positively associated with cannabis 
frequency and cannabis-related problems. This indicates that cannabis users are social 
individuals who seek out stimulation. Within Extraversion, the facet of Activity was only 
associated with cannabis use, not related problems. Individuals with lower activity levels 
seem more leisurely and relaxed. Previous studies have suggested that individuals use 
cannabis as a coping mechanism for social anxiety (Buckner & Schmidt, 2008). Further, 
cannabis use also can induce physiological responses of well-being and sedation (Julien, 
Advokat, & Comaty, 2011). The lack of association between cannabis-related problems 
and low Activity suggests that these individuals would not appear to be calm and relaxed, 
as a cannabis user who does not experience related problems may be perceived.  
As predicted, cannabis users of the last 6 months were lower in Conscientiousness 
and Agreeableness (Fridberg et al., 2011). While all correlations between cannabis use 
frequency, cannabis-related problems, and all facets of Conscientiousness and 
Agreeableness were negative, Modesty (A5) and Self-Efficacy (C1) were not 
significantly associated with the cannabis-related variables. Further, Morality was 
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negatively associated with cannabis-related problems only, suggesting that those who 
experience functional impairment from cannabis use are more guarded and willing to 
manipulate others, although this trait is not associated with cannabis use in general.  
When compared to non-users, cannabis users are lower in the Agreeableness 
facets of Trust, Cooperation, and Tendermindness. Thi  profile is consistent with 
individuals who are cynical realists who prefer logic to emotion, are not reluctant to 
express anger, and are skeptical of others. Cannabis users of the last 6 months were also 
lower in the Conscientiousness facets of Dutifulness, Achievement-Striving, Self-
Discipline, and Cautiousness. Terracciano and reseach rs (2008) also found cannabis 
users to be lower in Dutifulness and Deliberation. Based on this configuration, cannabis 
users may be unreliable, spontaneous, easily discouraged, engage in avoidance, and lazy 
or unmotivated; however, these individuals are often quite content with their lives and 
may not feel the need to fulfill moral obligations. This pattern of traits was also 
associated with schizotypy.   
Schizotypy and Personality 
The strongest associations with Neuroticism were total and positive schizotypy. 
Genetic research has indicated that 51% of the variation shared by Neuroticism and 
positive schizotypy can be accounted for by genetic influences (Macare, Bates, Heath, 
Martine, and Ettinger, 2012). Further, affect dysregulation and depression are common in 
schizophrenia-spectrum patients, and some research suggests that depressive symptoms 
may be indicative of later psychosis (Yung, Phillips, Yuen, & McGorry, 2004). The 
current data supports this idea, as Depression was the trongest Neuroticism facet-level 
association for total, positive, and negative schizotypy. Previous research has found 
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disorganized schizotypy to be associated with higher Neuroticism (Kerns, 2006). In 
addition to replicating this finding, the present study also found that the strongest facet 
correlation with disorganized schizotypy was Immoderation, which is strongly linked 
with cannabis use.      
Unlike the other factors and total schizotypy, disorganized traits were not 
associated with the domain of Extraversion. This may be because disorganized 
schizotypy was significantly associated with Friendliness in the negative direction, while 
the association with Excitement-Seeking was positive. Less friendliness and more 
reserved mannerisms were associated with all factors of schizotypy; moreover, the 
strongest association was found between negative schizotypy and Friendliness (r = -.61). 
This is in line with work by Ross and researchers (2002), in which they assert that 
positive schizotypy is harder to predict with the five-factor model than negative 
schizotypy. Interestingly, only the negative schizotypy factor was not significantly 
associated with Excitement-Seeking, as all other factors were positively correlated. When 
combined with the lack of association with Immoderation, it appears that negative 
schizotypal traits may serve as a protective factor against traits associated with substance 
use; however, the current data found no differences in negative schizotypy between the 
cannabis users and non-users. One possible explanation is hat individuals with negative 
schizotypy traits use cannabis for different reasons (e.g., alleviation of dysphoria through 
substance use) than those with trait impulsivity who seek stimulation.  
 Openness to Experience was positively associated with positive and total 
schizotypy, although the strongest correlation was to disorganized schizotypy. This is 
consistent with previous findings (Fridberg et al.,2011). This also has some degree of 
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face validity, as individuals high in Openness are perceived as unconventional and 
disorganized schizotypy is a measure of unusual speech and peculiar behavior. Negative 
schizotypy was associated with low facet Emotionality, much like cannabis use 
frequency. There are two possible reasons for these as ociations: Cannabis users and 
those with negative schizotypal traits inherently experience a lack of affect, which they 
try to increase through cannabis use, or cannabis is u ed to blunt negative affect.  
Much like the profile of cannabis users, schizotypy scores were associated with 
lower Agreeableness and Conscientiousness. At the domain level, only disorganized 
schizotypy was not significantly correlated with Agreeableness. At the facet level, no 
schizotypy factor was associated with Modesty, but positive, negative, and total 
schizotypy were negatively associated with every other facet of Agreeableness. This is 
consistent with individuals who are cynical, skeptical, self-centered, deceptive, and 
unsympathetic. When combined with low Conscientiousnes , it is understandable that 
individuals with schizotypal traits may have problems within social relationships. 
Conscientiousness was associated negatively with all factors of schizotypy at the 
domain and facet level, although low Conscientiousnes  was mostly strongly associated 
with total schizotypy.  At the facet level, all schizotypal traits were associated with the 
personality profile of individuals who lack ambition, are eager to quit, do not consider 
consequences, are unorganized, and may be unreliable. While this is extremely similar to 
the pattern of characteristics associated with cannabis use frequency, there is one 
important difference. As schizotypy increases, the fac t of Self-Efficacy decreases, 
indicating that schizotypal individuals feel that they are inept to deal with life and 
struggle with self-esteem. This association was not found with cannabis use frequency or 
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cannabis-related problems, suggesting that perception of self-inadequacy at the trait level 
is not due to impairment of social functioning due to cannabis use.  
Cannabis-Related Problems and Schizotypy  
After the sample was trichotomized according to the number of cannabis-related 
problems endorsed, there were no group differences i  positive schizotypy. This runs 
counter to the supersensitivity and dopamine hypotheses, as the effects of cannabis are 
similar to those of positive schizotypy, and more ponounced positive schizotypal traits 
were not observed in cannabis users or those with who have experienced one or more 
cannabis-related problems. While disorganized schizotypy was found to be different 
amongst the groups, post-hoc analyses revealed none of th se differences to be 
significant. When taken with the significant but weak correlation between these 
constructs, the data suggests that disorganized schizotypal traits do not increase as 
cannabis-related problems increase. This supports the aforementioned notion that 
disorganized schizotypy scores may be artificially inflated due to item wording that is 
biased towards individuals who use cannabis.   
 Negative schizotypy and total schizotypy scores were highest amongst those who 
only endorsed 1-2 cannabis related problems. This was unexpected, as one would expect 
those who meet criteria for harmful use/dependence of annabis (i.e., 3 or more items 
endorsed on the PUM), to have more elevated schizotypy symptoms. Previous literature 
(Najolia et al., 2012) and the supersensitivity model (Gregg et al., 2007) indicate that 
individuals with schizotypal traits endorse more cann bis-related problems. Refuting this 
notion is research by Gonzales, Bradizza, Vincent, Stasiewicz, & Paas (2007) which 
found no empirical evidence for the supersensitivity model, as dual-diagnosis patients 
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(i.e., individuals with schizophrenia and co-occurring substance use disorders), did not 
endorse more substance-related problems than individuals with only substance use 
diagnoses. Data from the current study is also contradictory of the supersensitivity model, 
as individuals who experienced few cannabis-related problems endorsed more negative 
schizotypal traits than those who reported problematic use.  
While not significant, the negative and total schizotypy scores in the three or more 
cannabis-related problems group were lower than those with 1-2 problems. This finding 
may not be significant within a larger sample, but this seems to be consistent with dual-
diagnoses (i.e., schizophrenia with co-occurring substance use) patients reporting less 
negative symptoms and better social skills (Potvin et al., 2006). This could also be 
explained by a ∆9-THC-induced increase in sociability (Julien et al., 2011). Although 
future research should examine this association with a larger sample, these results suggest 
that cannabis dependence may decrease negative schizotypal symptoms, concurrent with 
the alleviation of dysphoria model.  
The alleviation of dysphoria model of schizophrenia posits that individuals use 
cannabis to relieve boredom, depression, and loneliness, and aspects of these states may 
be tapped into by the negative schizotypy subscales of Constricted Affect and No Close 
Friends. It is plausible that individuals who meet criteria for cannabis dependence use the 
substance in social situations, which would lessen th  perception of alienation 
accompanying negative schizotypy. This is unlikely, however, because those who exhibit 
negative schizotypal traits aiming to decrease boredom and depression are likely to be 
introverted and not seek social interaction. Therefore, results of the present study 
superficially support the alleviation of dysphoria model. Research from Cohen and 
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associates (2011) also support this model, as those with schizotypy who use cannabis 
frequently reported significantly more cannabis-relat d problems, yet they were not more 
interested in treatment for reducing cannabis use. Th re is also the possibility that those 
who meet cannabis dependence criteria have underlying psychopathology traits, such as 
anxiety and depression (Degenhardt, Hall, & Lynskey, 2003), that are not expressed as 
schizotypal traits but contribute to poorer functioning, especially when combined with 
cannabis use. 
Cannabis-Related Problems and Personality 
The five-factor model associated with cannabis-related problems was very similar 
to that of cannabis use frequency, which included high Excitement-Seeking, high 
Immoderation, and low Emotionality. Given the high correlation between the two, this 
was expected. However, there are some specific differences between the two. 
Specifically, low Morality was associated with increased cannabis-related problems, 
suggesting that this trait tendency to be guarded may contribute to social functioning 
problems and decreased social support, leading to more cannabis-related problems. 
Problematic use was also not associated with relaxed nd slower physical pace, as 
cannabis use frequency was. Additionally, while not significant, the data showed the 
highest facet-level Anger in those with only one or two problems. This group also 
exhibited lower in Trust and Achievement-Striving. Together, these trait patterns are 
consistent with the current finding that this group re orted the highest levels of negative 
schizotypy. This indicates that those with more cannabis-related problems are less 
relaxed, more easily frustrated, more skeptical of others, and less motivated than cannabis 
users without related problems appear to be.  
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Those who endorsed one or more cannabis-related problems were much lower in 
Agreeableness and Conscientiousness than those who did n t experience cannabis-related 
problems. Moreover, those with 3 or more problems were even lower in 
Conscientiousness. Interestingly, a marginal difference was found in Dutifulness between 
1-2 and 3+ problem groups, which indicates that those who report a clinical number of 
cannabis-related problems are more likely to be unrliable than those without problematic 
cannabis use. It may be that individuals who are inh rently more undependable 
experience more cannabis-related problems because they may already fail to meet social, 
school, and/or work obligations.  
 Overall, it appears that problematic cannabis-users are spontaneous, novelty-
seeking individuals, who may be perceived as undependable and aggressive. This is 
consistent with Flory and colleagues’ (2002) research which found symptoms of cannabis 
dependence to be associated with low Agreeableness and Conscientiousness, as well as 
antisocial characteristics. Given that Morality decreases as cannabis-related problems 
increase, it is not surprising that those with dependence problems have antisocial 
personality traits, such as willingness to manipulate others. Although not significant, 
Immoderation increased with number of cannabis problems, which is congruent with 
previous findings that impulsivity strengthened theassociation between cannabis use and 
related problems. When combined with lack of motivation or ambition, it is 
understandable that these individuals’ experience more impairment in social and general 
functioning due to cannabis use. It is important to note that some social functioning 
problems may be related to an individual’s ability to recognize and interpret emotions of 
others. 
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Emotion Recognition  
 Contrary to previous research (Perlman et al., 2009), Neuroticism was not 
significantly associated with fixation on features of any emotion, including negative 
expressions. However, facet-level Anxiety was positively associated with sad face 
identification accuracy, while Immoderation decreased neutral face accuracy. Higher 
depression scores increased fixation on angry eyes, while Self-Consciousness decreased 
fixation on all mouths (e.g., angry, disgust, sad, happy, and neutral mouths). These 
findings partially support the trait-congruency hypothesis (Bargh et al., 1988), as anxious 
individuals were better at identifying sad faces and depression increased attention to 
angry eyes.  
An interesting finding was the negative pattern betwe n Extraversion and fixating 
on angry and neutral eyes. Those high in Friendliness avoided angry eyes. Further, the 
Extraversion facets of Excitement-Seeking and Cheerfulness decreased accuracy in 
identifying sad faces. Individuals higher in Excitem nt-Seeking fixated more on angry 
and neutral mouths. Cheerfulness or positive emotion was also negatively associated with 
accuracy for sad faces. These findings partially support the trait-congruency hypothesis, 
as traits indicative of social individuals were associated with decreased accuracy for 
identifying sadness and avoidance of angry eyes. As mentioned above, trait anxiety had 
the exact opposite association with identifying sadness, which fits conceptually and with 
the research of Bradley, Mogg, and Millar (2000), who found that those with anxiety tend 
to be hyperviligant toward negative social cues.   
Contrary to the trait-congruency hypothesis was the association between Trust 
and the ability to recognize disgust, while Liberalism decreases the accuracy for 
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identifying disgust. Intellect increased ability to identify sad faces, although there is no 
obvious explanation for this association. Overall emotional identification accuracy 
increased with Conscientiousness facets of Self-Efficacy and Cautiousness. Reduction is 
accuracy was associated with more Excitement-Seeking. Individuals with schizotypy and 
users of cannabis are both low in Conscientiousness and higher in Excitement-Seeking, 
(with the exception of negative schizotypal traits). Previous research indicates that these 
individuals exhibit deficits in emotional identification.  
Based on previous findings, one would expect cannabis-related variables (Platt et 
al., 2010) and schizotypy (Germine & Hooker, 2010) to be associated with this facial 
affect recognition. Although cannabis use frequency and related problems were not 
associated with accuracy, positive, disorganized, an  total schizotypy were associated 
with inaccuracy in identifying neutral faces. Attenuated attention to prominent facial 
features when viewing neutral expressions has been found in schizophrenia (Loughland 
et al., 2002). Conversely, fixation duration on neutral mouths was positively associated 
with disorganized schizotypy in the present study, suggesting that focusing on the mouth 
of neutral faces makes these expressions harder to identify. This is corroborated by the 
fact participants with higher positive, disorganized, and total schizotypal traits were more 
inaccurate in identifying neutral faces. 
Inconsistent with the findings of Perlman and colleagues (2009), 
Conscientiousness was significantly associated with avoidance of neutral and angry 
mouths in this sample, whereas they found a negative ssociation between 
Conscientiousness and attention to emotional eyes. Because Conscientiousness was also 
associated with accuracy in identifying neutral faces, it would appear that those with high 
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in this trait use a visual scanning method that is effective. Countering this idea is the 
finding that Self-Discipline decreased accuracy for identifying happy faces; however, this 
may be because those high in Self-Discipline avoided th  mouths of angry, disgust, 
happy, and neutral mouths.  
An unexpected pattern emerged between number of cannabis-related problems 
and avoiding the eyes of most emotional faces, (e.g., disgust, happy, sad, and neutral). 
Those with more cannabis problems did spend more tim  on angry mouths, like those 
with scoring higher in disorganized schizotypy. Therefore, this avoidance of the eyes may 
be related to inaccuracy when identify neutral faces. This would also explain why 
accuracy for happy faces was positively associated with positive, disorganized, and total 
schizotypy, as these individuals focus on the mouth. In the happy pictures, identification 
of the positive emotion may be easier when focusing on the mouth, which would explain 
why those high in Self-Discipline who avoid mouths, can easily identify neutral mouths 
but are more inaccurate with happy expression.  
 A significant finding was the negative association between cannabis use 
frequency and left lateralization preference. Inattention to the left side of emotional faces 
is often seen in schizophrenia (Loughland et al., 2002; Phillips & David, 1997). Because 
there were no associations with schizotypy and lateralization preference, it may be that 
emotional recognition deficits previously seen in schizophrenia and cannabis use may be 
related to dopaminergic alterations in the frontal lobe and not necessarily an underlying 
etiological factor which leads to both. For example, high Emotionality was associated 
with decreased visual attention to the right side of faces, so individuals with lower 
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Emotionality may spend more time on the right side of the face, such as those who use 
cannabis and/or exhibit negative schizotypal traits. 
 Findings of a recent study by Abbott and Green (2013) contradict the findings of 
the current study. In their sample, negative schizotypy was associated with reduced 
accuracy in identifying emotions. One reason for this discrepancy is the calculation of 
negative schizotypal symptoms. Abbott and Green (2013) included the subscales of 
Social Anxiety and Suspiciousness, in addition to No Close Friends and Constricted 
Affect. Because this study used the SPQ-BR, Suspiciousness was captured under positive 
schizotypy. This makes sense conceptually, as suspiciousness is an attenuated form of 
paranoia. Further, Abbott and Green found the strongest correlation between facial affect 
identification inaccuracy and social anxiety, which s not a core construct of schizotypy. 
Due to these potential limitations, the findings of the current study may better reflect 
associations between schizotypy and the ability to rec gnize universal human emotions. 
Limitations  
The aforementioned results conclusions should be interpreted in light of the 
following limitations. First, this study relied on self-report measures for variables related 
to cannabis use, schizotypy, and personality. While typ  of assessment is frequently used 
and is considered an acceptable means of obtaining data (Baumeister, Vohs, & Funder, 
2007), underreporting is possible. This is especially true for sensitive items related to 
cannabis use, given its Schedule I classification in the United States (DOJDEA, 2012). 
Despite the heavy use of self-report questionnaires, b havioral measures were collected 
through the use of the eye tracker.   
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The current sample lacks diversity, as most participants were White. It should be 
noted that the sample was largely consistent with the demographic make-up of the 
regional university where the data was collected. Aditionally, because the sample is 
comprised of college undergraduates, these results may not generalize to a larger 
population; however, the frequency of daily use of th se who reported cannabis use in the 
last 6 months suggests that these results may be generalizable to non-college young 
adults who use cannabis.  The results of the current study may not extend to individuals 
with clinical schizotypal symptoms or individuals outside of the emerging adulthood age 
range, (i.e., adolescence, middle-age, and elderly populations); however, these results 
may be useful in understanding sub-clinical symptoms related to the schizophrenia-
spectrum, given its dimensional nature (Rössler et al., 2012).   
There are several potential cofounding variables that were not taken into account 
in the current study. For example, based on the resea ch of Teracciano and researchers 
(2008), cigarette smokers have a very similar personality profile to current marijuana 
users. When added to the fact that cannabis and tobacc  use often co-occur (Agrawal, 
Silberg, Lynskey, Maes, & Eaves, 2010), not controlling for cigarette use is a potential 
limitation of this study. Further, although trait depression was not strongly associated 
with cannabis use or schizotypy, state depression and social anxiety, (Najolia et al., 2012) 
have been found to be comorbid with the previously mentioned groups. Further, 
psychiatric history and family histories were not taken, which could have strengthened 
the assessment of schizotypy.   
For the eye tracker portion of the study, it is possible that the results may have 
been skewed by participants’ head movements. Leonards and Mohr (2009) corrected this 
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by including a point of fixation between pictures to correct for natural movement.  
Additionally, a stationary chair would provide a more restrictive range of motion for the 
participant during the task. Although this study utilized pictures from the Pictures of 
Facial Affect series (Ekman, 1993), which is has stndardized and highly used in 
research, these are static representations of emotion and are not ethnically diverse. 
Ecological validity may increase with use of a video with context when assessing 
processing of emotion (Miller & Lenzenweger, 2012). The set of 34 pictures used in the 
eye-tracking task were unequal in the frequency of emotional faces represented. This 
study did not assess fearful or surprise faces, two universal emotional expressions. By 
having only one key for negative emotions, (i.e., sad, angry, and disgust), and only one 
positive emotion (i.e., happy), the participants may h ve anticipated hitting the button 
corresponding to negative emotions because these were higher in proportion.  
It should also be noted that an item analysis of the emotional accuracy data 
revealed that the accuracy of happiness was the least r liable of all emotions. This may be 
because so many participants could accurately identify the positive emotional faces. In 
fact, two of the happy face stimuli had 100% accuray, which reduced the reliability of 
the task. Continuing research may want to use attenua d versions of emotions, thus 
making identification harder, and the testing of the ability to distinguish emotions more 
reliable. While the task created in the current study exhibited poor reliability (i.e., α = 
.52), to this author’s knowledge, no previous emotion recognition research has taken 
reliability into account (e.g., Abbott & Green, 2013; Perlman et al., 2009; Platt et al., 
2010). Last, the bivariate correlations were not corrected for Type I error inflation, and a 
Poisson regression may have been a better choice to analyze the data. Future endeavors 
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researching cannabis use, schizotypy, and personality should take these limitations into 
account and aim to improve this methodology.  
Future Directions 
 Future studies should examine the association between cannabis use and 
disorganized schizotypy. A longitudinal study could determine whether disorganized 
schizotypy is exacerbated by cannabis use, or if this correlation is due to the short-term 
cognitive effects of cannabis intake. Individuals at the subclinical significance for 
cannabis dependence exhibited more negative and overall schizotypal traits than those 
who met criteria for cannabis dependence. Further research should focus on individuals 
who fall into this sub-clinical threshold category, as these young adults may have 
potential dysfunction-provoking traits not found in individuals with cannabis dependence 
disorders. Longitudinal studies could also contribute to a greater understanding of the 
association between cannabis use, schizotypy, Agreeabl ness, and Conscientiousness. 
Future research should also focus on predicting cannabis-related problems, as this is 
indicative of current problems in social and general functioning, as well as potential for 
later psychopathology. Based on the current findings, there are personality differences 
between individuals who use cannabis, and those who develop cannabis-related problems 
and dependence. Potential avenues of research include finding psychological markers 
which can predict dependent, problematic versus recreational use.    
Future studies may also want to evaluate gender differences between the variables 
of interest in this study. It is well-accepted that Neuroticism is generally higher in 
females (Costa, Terracciano, & McCrae, 2001), while cannabis use frequency 
(SAMHSA, 2011), schizotypy (Cohen et al., 2010) andOpenness to Experience (Perlman 
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et al., 2009) are typically higher in males. Rubinstein (2005) noted that men are often 
exhibit lower Agreeableness and Conscientiousness than women, which may be one 
reason why males are more likely to engage in cannabis use. Females were better at 
emotion identification within this sample, which is consistent with previous literature 
(Hampson, van Anders, & Mullin, 2006). The differenc s in cannabis use, personality, 
schizotypy, and emotional identification may indicate  need for gender-specific 
interventions and treatments.  
 Previous research has found that individual differences, such as mood (Schmid, 
Schmid Mast, Bombari, Mast, & Lobmaier, 2011), and schizophrenia-spectrum 
symptoms (Bellgrove, Vance, & Bradshaw, 2003; Landgraf et al., 2011) affect 
information processing strategies, (i.e. global versus local processing). When combined 
with the fixation on certain facial features and facial affect recognition associations with 
schizotypy and personality variables found in the present study, upcoming research 
should explore information processing differences in chizotypy and personality. Another 
potential avenue of research would be incorporating fMRI technology when exploring the 
association between the variables of interest in the present study. While brain activation 
when viewing emotional faces has been done by Fusar-Poli and associates (2009), only 
used fearful faces were used as stimuli. 
 The upcoming DSM-V includes attenuated psychosis syndrome, which involves 
attenuated positive and disorganized symptoms that occur at least once a week for one 
month, into Section III, conditions requiring further study (as cited in Carpenter & van 
Os, 2011). The current study, as well as previous and future schizotypy research, should 
be applied when investigating attenuated psychosis syndrome. For example, the role of 
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cannabis use and personality in attenuated psychosis syndrome warrant exploration. 
Further, if this condition is on the schizophrenia-spectrum, examining eye-tracking and 
emotional identification patterns may be valuable when assessing attenuated psychosis 
syndrome.  
Conclusion  
The present research is consistent with previous findings of associations between 
cannabis use and schizotypy. There was a clear associ tion between cannabis use and 
disorganized schizotypy, although more research needs to be done to determine if this 
relationship is inflated due to the cognitive effects of cannabis ingestion, rather than a 
predisposition for schizophrenia-spectrum disorders. Results of the current study were 
inconsistent with the supersensitivity model of schizophrenia, as positive schizotypy 
symptoms were not significantly higher as a function of cannabis-related problems. The 
findings partially supported the alleviation of dysphoria model, as negative schizotypy 
was higher in those with one to two cannabis related problems, but not individuals with 
clinical levels of cannabis-related problems.     
Regarding the five-factor model, low Agreeableness and Conscientiousness were 
associated with cannabis use, related problems, and schizotypy. The strongest association 
observed in this study at the domain level of personality was between total schizotypy 
scores and Neuroticism. At the facet level, the association between low Friendliness and 
negative schizotypy was strongest, which is consistent with the conceptualization of 
negative schizotypy as traits related to reserved or restricted affect and poorer 
interpersonal functioning. Individuals endorsing a clinical number of cannabis-related 
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problems were higher in Excitement-Seeking, but lower in Cooperation, Dutifulness, and 
Cautiousness compared to individuals with no cannabis-related problems.  
  Individuals with positive and disorganized schizotypy exhibited deficits 
identifying neutral faces, but were better at recognizing happy faces. Conversely, as 
Conscientiousness increased, as did the ability to identify neutral faces, and this 
association appeared to be driven by the facets of Self-Efficacy, Self-Discipline, and 
Cautiousness. These facets were also negatively associ ted with fixation on neutral 
mouths, suggesting that individuals high in these specific traits use a successful visual 
scanning process when processing emotional ambivalent stimuli. Considering that these 
traits are lower in cannabis users, it is conceivable that lacking these traits increases 
inaccuracy. Cannabis-related problems were associated wi h avoidance of the eyes for 
most emotions, similar to individuals with schizophrenia. Moreover, as cannabis use 
increased, attention to the left side of the face decreased. This left visual field deficit is 
commonly seen in schizophrenia; therefore, dopaminergic alteration may explain some of 
the phenotypical similarities between these populations.  
Overall, the results of the current study indicate that cannabis use tends to 
increase disorganized schizotypal symptoms. Schizotypy and cannabis use also share a 
number of personality characteristics, particularly low Agreeableness and Conscientious, 
which may increase the likelihood of seeking out cannabis and experiencing related 
problems. Additionally, these personality traits play a role in the visual strategies used by 
these individuals to identify emotions of others. Because those experiencing social 
dysfunction may isolate themselves due to particular personality traits, prevention of 
cannabis use, detection of schizotypy, and training in social skills during adolescence and 
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early adulthood would be most helpful in preventing later cannabis-related problems and 
emotional identification deficits.   
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APPENDIX A 
Informed Consent Form for Thoughts, Habits, and Consequences Study 
What is the purpose of this research? 
The purpose of this research is to explore the relationships among personality 
traits and multiple negative outcomes, including potential cannabis-related problems and 
emotion processing tendencies in students.   
What will be expected of me?   
If you are a student and you are 18 years of age or older, you are eligible to 
participate in this study; however, individuals who are legally blind are not eligible due to 
the eye-tracking portion of the study. First, you will be introduced to the study, including 
risks and benefits, and if you want to participate, you will sign an informed consent form 
prior to filling out the study survey. Participation is completely voluntary, and you can 
decide to withdraw from the study at any time without penalty. If you consent to 
participation, you may be given research credits (units), extra credit points, or other types 
of points toward a course grade as determined by your instructor. No other reward 
(monetary or otherwise) will be provided for participation. 
Next, you will be asked to fill out a packet of surveys, which will take 
approximately 30 minutes. Some people need more or less time, but we will ask you to 
please read each question carefully. Please do not put your name on any of the 
questionnaires – only on the consent forms! When you have completed the packet of 
questionnaires, you will return the packet and the informed consent form to the 
experimenter and he or she will separate the consent form from the rest of the packets. 
This keeps your responses confidential. When you return your informed consent form 
and questionnaire packet, you will also be given a Debriefing Form that further explains 
the purpose of the study and lists contact information for the researcher and appropriate 
resources. After completing these surveys, you may be contacted to complete the second 
portion of the study. This non-invasive procedure includes sitting at a computer monitor 
and looking at images of facial expressions for approximately 10 minutes.  
How long with the research take? Survey: Approx. 30 min.; Eye-tracker: 5 min. 
Will my answers be anonymous? 
Your answers will remain confidential. Specifically, you will not be asked to 
provide your name or identifying information on the surveys. Your consent form is the 
only form that will have your name on it, and it will be separated from your survey 
packet. The surveys and consent forms will be kept in separate files in a locked office. 
Your responses will only be linked to your answers if you are eligible for the second 
portion of the study. (Not every participant will be selected for this portion.) If you 
contacted for the second portion of the study, you files will be re-entered into separate 
files as before.  
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Can I withdraw from the study if I decide to?  
Yes! You can withdraw from the study at any time without penalty. If you opt to 
withdraw, your surveys will be removed from the study and destroyed. 
 
Is there any harm that I might experience from taking part in the study? 
There are no risks of physical or psychological harm. Because all information 
regarding illicit drug use will be kept separate from the consent forms, there are no 
foreseeable legal or social risks. Other than transient emotional discomfort that you may 
experience as a result of reflecting on your symptos and perceptions while filling out 
the surveys, every effort will be made to ensure your safety and well-being. Specifically, 
the experimenter will remain alert and you can ask questions at any time. Also, the 
debriefing form will list resources available to students (free of charge) in the event you 
should experience more lasting distress.  
How will I benefit from taking part in the research? 
Participants will earn one credit for completing the surveys. An additional credit 
will be given for completing the eye tracking portin. In addition to the direct benefit of 
earning points toward a course, the potential benefits to participants include the following 
opportunities: experiencing first-hand how researche s conduct studies and gather 
information in this type of psychological research, receiving an individualized personality 
profile, and reflecting on your own experiences andperceptions as evoked by your 
participation. Finally, your participation may ultimately inform clinicians, researchers, 
consumers, and the community at large regarding the relationships among study variables 
that are included in our research.  
 Who should I contact if I have questions or concerns about the research? 
Contact me, Brittany Blanchard, at beblanchard@email.wcu.edu. You can also 
contact Dr. Åsberg, faculty director of the project, at 828-227-3451 (or 
kasberg@email.wcu.edu). If you have concerns about your treatment as a participant in 
this study, contact the chair of WCU’s Institutional Review Board through the office of 
Research Administration at WCU (828-227-7212). 
  
*If you would like to receive your personality profile, put your contact information (e-
mail address, mailing address, or phone number) below your signature. 
Name__________________________________ 
Signature__________________________________ Date: _____ ______ 
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APPENDIX B 
Informed Consent Form for Thoughts, Habits, and Consequences Study 
What is the purpose of this research?  
The purpose of this research is to explore the relationships among personality 
traits and multiple negative outcomes, including potential cannabis-related problems and 
emotion processing tendencies in students.   
 
What will be expected of me?   
If you are a student and you are 18 years of age or older, you are eligible to 
participate in this study; however, individuals who are legally blind are not eligible due to 
the eye-tracking portion of the study. Because you have been contacted to participate in 
this portion of the Thoughts, Habits, and Consequences Study, you have already been 
introduced to the study. If you wish to participate, you will sign this consent form prior to 
the start of the eye-tracking task. Participation is completely voluntary, and you can 
decide to withdraw from the study at any time without penalty. If you consent to 
participation, you will be compensated through research credit. No other reward 
(monetary or otherwise) will be provided for participation. When you return your consent 
form, we will begin. This non-invasive procedure involves sitting at a computer monitor 
and looking at images of various facial expressions.  
 
How long with the research take? Approx. 5 minutes 
 
Will my answers be anonymous? 
Your performance will remain confidential. Your conse t form is the only form 
that will have your name on it. All data collected from the eye-tracker will be analyzed 
using assigned participant identification numbers to further ensure confidentiality.  
 
Can I withdraw from the study if I decide to?  
Yes! You can withdraw from the study at any time without penalty. If you opt to 
withdraw, your surveys and eye-tracking data will be removed from the study and 
destroyed. 
 
Is there any harm that I might experience from taking part in the study? 
There are no risks of physical or psychological harm related to this study. Because 
all information regarding illicit drug use will be kept separate from the consent forms, 
there are no foreseeable legal or social risks. With regard to the eye-tracker, participants 
may feel mild discomfort when looking at sad or angry faces; however, this discomfort is 
no greater than one would experience in daily life.Also, the debriefing form will list 
resources available to students (free of charge) in the event you should experience more 
lasting distress.  
 
How will I benefit from taking part in the research? 
In addition to the credit you have received for completing the survey, another 
credit may be given for completing the eye tracking portion (depending on the number of 
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extra credits awarded by your instructor and/or your course requirement for research 
participation)Other potential benefits to participants include the following opportunities: 
experiencing first-hand how researchers conduct studies and gather information in this 
type of psychological research, receiving an individualized personality profile (survey 
portion), and reflecting on your own experiences and perceptions as evoked by your 
participation. Finally, your participation may ultimately inform clinicians, researchers, 
consumers, and the community at large regarding the relationships among study variables 
that are included in our research.  
 
Who should I contact if I have questions or concerns about the research? 
Contact me, Brittany Blanchard, at beblanchard@email.wcu.edu. You can also 
contact Dr. Åsberg, faculty director of the project, at 828-227-3451 (or 
kasberg@email.wcu.edu). If you have concerns about your treatment as a participant in 
this study, contact the chair of WCU’s Institutional Review Board through the office of 
Research Administration at WCU (828-227-7212). 
 
 
Name__________________________________ 
 
Signature__________________________________ Date: _____ ______ 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
105 
 
 
APPENDIX C 
Debriefing Form 
Project Title: Thoughts, Habits, and Consequences Study 
Investigator: Brittany Blanchard, B.S., Department of Psychology, WCU 
Thank you for participating in the Thoughts, Habits, and Consequences Study. As 
stated in the informed consent form, the purpose of this study is to investigate the 
relationships among aspects of personality and substance use. Specifically, we are 
examining which personality factors contribute to cannabis-related problems. We are also 
interested in the relationship between personality, cannabis use, and how individuals 
interpret facial expressions. Overall, the findings may contribute to the study of 
personality, substance-related problems, and emotion processing. Additionally, 
participation in this study may contribute to a greater understanding of oneself, should 
you choose to receive your five factor personality profile.  
If you have questions about any aspect of this study, please feel free to contact the 
investigator, Brittany Blanchard at beblanchard@email.wcu.edu. You may also contact 
the faculty supervisor, Dr. Åsberg, via email at kasberg@wcu.edu or via phone 828-227-
3451. You can also contact the IRB Chair at 828-227-31 7. Finally, if you are 
experiencing distress as a result of participating in this study or would like to speak with 
a mental health professional regarding emotional or substance use problems, please 
contact the Counseling Center at Western Carolina Uiversity, (828)-227-7469, which 
offers services to students free of charge. Please contact the investigator for additional 
resources if needed.  
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APPENDIX D 
Demographic Information: 
 
Age: _____________________________ 
Gender: ___________________________ 
Ethnicity: _________________________ 
WCU Classification: ________________ 
Major: ___________________________ 
GPA: ____________________________ 
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APPENDIX E 
Schizotypal Personality Questionnaire- Brief Revised (SPQ-BR) 
 
1. Do you often feel nervous when you are in a group of unfamiliar people? 
Strongly Disagree    Disagree        Neutral       Agree    Strongly Agree 
            
  
2. I am an odd, unusual person. 
Strongly Disagree    Disagree        Neutral       Agree    Strongly Agree 
             
   
3. Do you believe in telepathy (mind-reading)? 
Strongly Disagree    Disagree        Neutral       Agree    Strongly Agree 
             
 
4. Other people see me as slightly eccentric (odd). 
Strongly Disagree    Disagree        Neutral       Agree    Strongly Agree 
             
 
5. I sometimes jump quickly from one topic to another when speaking. 
Strongly Disagree    Disagree        Neutral       Agree    Strongly Agree 
             
  
6. I tend to keep my feelings to myself. 
Strongly Disagree    Disagree        Neutral       Agree    Strongly Agree 
             
  
7. I often hear a voice speaking my thoughts aloud. 
Strongly Disagree    Disagree        Neutral       Agree    Strongly Agree 
             
  
8. Do you tend to wander off the topic when having a conversation? 
Strongly Disagree    Disagree        Neutral       Agree    Strongly Agree 
             
  
9. I rarely laugh and smile. 
Strongly Disagree    Disagree        Neutral       Agree    Strongly Agree 
             
   
10. I often feel that others have it in for me. 
Strongly Disagree    Disagree        Neutral       Agree    Strongly Agree 
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11.   I get anxious when meeting people for the first time. 
Strongly Disagree    Disagree        Neutral       Agree    Strongly Agree 
            
 
12.   Do you believe in clairvoyance (psychic forces, fortune telling)? 
Strongly Disagree    Disagree        Neutral       Agree    Strongly Agree 
             
 
13.   When you look at a person or yourself in a mirror, have you ever seen the face   
         change right before your eyes? 
Strongly Disagree    Disagree        Neutral       Agree    Strongly Agree 
             
  
14.  Do you feel that you cannot get “close” to people? 
Strongly Disagree    Disagree        Neutral       Agree    Strongly Agree 
             
 
15.   I often ramble on too much when speaking. 
Strongly Disagree    Disagree        Neutral       Agree    Strongly Agree 
             
 
16.   I feel very uncomfortable in social situations involving unfamiliar people. 
Strongly Disagree    Disagree        Neutral       Agree    Strongly Agree 
             
 
17.   I find it hard to be emotionally close to other po le. 
Strongly Disagree    Disagree        Neutral       Agree    Strongly Agree 
             
 
18.    Do you sometimes feel that people are talking about you?  
Strongly Disagree    Disagree        Neutral       Agree    Strongly Agree 
               
 
19.   I sometimes avoid going to places where there will be many people because I will   
  get anxious. 
Strongly Disagree    Disagree        Neutral       Agree    Strongly Agree 
             
 
20.   Have you had experiences with astrology, seeing the future, UFO’s, ESP, or a sixth   
  sense? 
Strongly Disagree    Disagree        Neutral       Agree    Strongly Agree 
             
 
21.   Are your thoughts sometimes so strong that you can almost hear them? 
Strongly Disagree    Disagree        Neutral       Agree    Strongly Agree 
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22.   Have you ever felt that you are communicating with another person telepathically  
  (by mind- reading)? 
Strongly Disagree    Disagree        Neutral       Agree    Strongly Agree 
             
 
23.   I sometimes forget what I am trying to say. 
Strongly Disagree    Disagree        Neutral       Agree    Strongly Agree 
             
 
24. Do you sometimes get concerned that friends or co-workers are not really loyal or 
trustworthy? 
Strongly Disagree    Disagree        Neutral       Agree    Strongly Agree 
             
 
25. Do you sometimes feel that other people are watching you? 
Strongly Disagree    Disagree        Neutral       Agree    Strongly Agree 
             
 
26. When shopping, do you get the feeling that other people are taking notice of you? 
 Strongly Disagree    Disagree        Neutral       Agree    Strongly Agree 
             
  
27. Do everyday things seem unusually large or small? 
Strongly Disagree    Disagree        Neutral       Agree    Strongly Agree 
             
 
28. Do you often have to keep an eye out to stop people from taking advantage of you? 
Strongly Disagree    Disagree        Neutral       Agree    Strongly Agree 
             
 
29. Do you feel that there is no one you are really close to outside of your immediate 
family, or people you can confide in or talk to about personal problems? 
Strongly Disagree    Disagree        Neutral       Agree    Strongly Agree 
             
 
30.   I have some eccentric (odd) habits. 
Strongly Disagree    Disagree        Neutral       Agree    Strongly Agree 
            
 
31.   People sometimes comment on unusual mannerisms and habits. 
Strongly Disagree    Disagree        Neutral       Agree    Strongly Agree 
           
 
32. I am not good at expressing my true feelings by the way I talk and look.  
Strongly Disagree    Disagree        Neutral       Agree    Strongly Agree 
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APPENDIX F 
Cannabis Use Disorders Identification Test (CUDIT) 
Over the past 6 months... 
1. How often did you use cannabis? 
 Never         Monthly or less        2-4x a month       2-3x a week      4 or more x a week 
                    
2. How many hours were you "stoned" on a typical day when you had been using 
cannabis? 
      1 or 2          3 or 4                      5 or 6                  7 to 9                10 or more 
                    
3. How often were you "stoned" for 6 or more hours? 
      Never       Less than monthly        Monthly              Weekly        Daily or almost daily 
                    
4. How often did you find that you were not able to s p using cannabis once you had 
started?  
      Never       Less than monthly        Monthly              Weekly        Daily or almost daily 
                    
5. How often did you fail to do what was normally exp cted from you because of using 
cannabis?  
      Never       Less than monthly        Monthly              Weekly        Daily or almost daily 
                    
6. How often did you needed to use cannabis in the morning to get yourself going after a 
heavy session of using cannabis?  
      Never       Less than monthly        Monthly              Weekly        Daily or almost daily 
                    
7. How often did you have a feeling of guilt or remorse after using cannabis? 
      Never       Less than monthly        Monthly              Weekly        Daily or almost daily 
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8. How often have you had a problem with your memory or concentration after using  
cannabis?  
      Never       Less than monthly        Monthly              Weekly        Daily or almost daily 
                    
9. Have you or someone else been injured as a result of your use of cannabis? 
      No                     Yes 
                  
10. Has a relative, friend or doctor or other health worker been concerned about your use 
of cannabis or suggested you cut down?  
      No                     Yes 
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APPENDIX G 
Problematic Use of Marijuana (PUM) 
Please read each item and circle your response. 
1) Have you ever skipped school classes or came late to school because of cannabis use?  
Yes      No 
2) Have you had a serious argument with family membrs ecause of your cannabis use? 
Yes      No 
3) Have you had a serious argument with friends because of your cannabis use? 
Yes      No 
4) Have you ever bought cannabis yourself? 
Yes     No 
5) Do you have more and more problems in studying and understanding new 
information? 
Yes     No 
6) Have you ever used cannabis when you were alone? 
Yes     No 
7) Do you often feel desire for cannabis? 
Yes     No 
8) Have you ever spent so much money on cannabis that you had to resign from other 
things or activities?  
Yes     No 
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APPENDIX H 
M5-120 Questionnaire 
David M. McCord, Ph.D., Western Carolina University 
Age: _____    M     F     Date: __________________ 
 
 
 
 
 
 
 
 
 
 
 
 
This is a personality questionnaire, which should take about 15 minutes. There are no right or wrong 
answers to these questions; you simply respond with the choice that describes you best.  
 
If you feel that you cannot see the questions appropriately because of sight difficulties, cannot use a pencil 
well because of hand-motor problems, or know of any other physical, emotional, or environmental issues 
which would affect your performance on this test, please notify the testing administrator now.  
 
The M5 Questionnaire is used primarily for research purposes, though in certain cases individual results 
may be shared with the test-taker through a professional consultation. In general, results are treated 
anonymously and are combined with other data in order to develop norms, establish psychometric 
properties of these scales and items, and to study various theoretical and practical issues within the field 
of personality psychology.  
 
By proceeding with the process and responding to these questionnaire items, you are expressing your 
understanding of these terms and your consent for your data to be used for research purposes. You are 
also agreeing to release and forever discharge Western Carolina University and David M. McCord, 
Ph.D., from any and all claims of any kind or nature whatsoever arising from the assessment process. 
 
• Without spending too much time dwelling on any one item, just give the first 
reaction that comes to mind.  
• In order to score this test accurately, it is very important that you answer very item, 
without skipping any. You may change an answer if you wish. 
• It is ultimately in your best interest to respond as honestly as possible. Mark the 
response that best shows how you really feel or see yourself, not responses that you 
think might be desirable or ideal. 
Turn the page over now 
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Page 2
Innacurate
Moderately 
Innacurate Neither
Moderately 
Accurate Accurate
1 Worry about things. O O O O O
2 Make friends easily. O O O O O
3 Have a vivid imagination. O O O O O
4 Trust others. O O O O O
5 Complete tasks successfully. O O O O O
6 Get angry easily. O O O O O
7 Love large parties. O O O O O
8 Believe in the importance of art. O O O O O
9 Use others for my own ends. O O O O O
10 Like to tidy up. O O O O O
11 Often feel blue. O O O O O
12 Take charge. O O O O O
13 Experience my emotions intensely. O O O O O
14 Love to help others. O O O O O
15 Keep my promises. O O O O O
16 Find it difficult to approach others. O O O O O
17 Am always busy. O O O O O
18 Prefer variety to routine. O O O O O
19 Love a good fight. O O O O O
20 Work hard. O O O O O
21 Go on binges. O O O O O
22 Love excitement. O O O O O
23 Love to read challenging material. O O O O O
24 Believe that I am better than others. O O O O O
25 Am always prepared. O O O O O
26 Panic easily. O O O O O
27 Radiate joy. O O O O O
28 Tend to vote for liberal political candidates. O O O O O
29 Sympathize with the homeless. O O O O O
30 Jump into things without thinking. O O O O O
31 Fear for the worst. O O O O O
32 Feel comfortable around people. O O O O O
33 Enjoy wild flights of fantasy. O O O O O
34 Believe that others have good intentions. O O O O O
35 Excel in what I do. O O O O O
36 Get irritated easily. O O O O O
37 Talk to a lot of different people at parties. O O O O O
38 See beauty in things that others might not notice. O O O O O
39 Cheat to get ahead. O O O O O
40 Often forget to put things back in their proper place. O O O O O
Innacurate Moderately 
Innacurate
Neither Moderately 
Accurate
Accurate
M5-120 Questionnaire
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Innacurate
Moderately 
Innacurate Neither
Moderately 
Accurate Accurate
41 Dislike myself. O O O O O
42 Try to lead others. O O O O O
43 Feel others' emotions. O O O O O
44 Am concerned about others. O O O O O
45 Tell the truth. O O O O O
46 Am afraid to draw attention to myself. O O O O O
47 Am always on the go. O O O O O
48 Prefer to stick with things that I know. O O O O O
49 Yell at people. O O O O O
50 Do more than what's expected of me. O O O O O
51 Rarely overindulge. O O O O O
52 Seek adventure. O O O O O
53 Avoid philosophical discussions. O O O O O
54 Think highly of myself. O O O O O
55 Carry out my plans. O O O O O
56 Become overwhelmed by events. O O O O O
57 Have a lot of fun. O O O O O
58 Believe that there is no absolute right or wrong. O O O O O
59 Feel sympathy for those who are worse off than myself. O O O O O
60 Make rash decisions. O O O O O
61 Am afraid of many things. O O O O O
62 Avoid contacts with others. O O O O O
63 Love to daydream. O O O O O
64 Trust what people say. O O O O O
65 Handle tasks smoothly. O O O O O
66 Lose my temper. O O O O O
67 Prefer to be alone. O O O O O
68 Do not like poetry. O O O O O
69 Take advantage of others. O O O O O
70 Leave a mess in my room. O O O O O
71 Am often down in the dumps. O O O O O
72 Take control of things. O O O O O
73 Rarely notice my emotional reactions. O O O O O
74 Am indifferent to the feelings of others. O O O O O
75 Break rules. O O O O O
76 Only feel comfortable with friends. O O O O O
77 Do a lot in my spare time. O O O O O
78 Dislike changes. O O O O O
79 Insult people. O O O O O
80 Do just enough work to get by. O O O O O
Innacurate Moderately 
Innacurate
Neither Moderately 
Accurate
Accurate
M5-120 Questionnaire
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Innacurate
Moderately 
Innacurate Neither
Moderately 
Accurate Accurate
81 Easily resist temptations. O O O O O
82 Enjoy being reckless. O O O O O
83 Have difficulty understanding abstract ideas. O O O O O
84 Have a high opinion of myself. O O O O O
85 Waste my time. O O O O O
86 Feel that I'm unable to deal with things. O O O O O
87 Love life. O O O O O
88 Tend to vote for conservative political candidates. O O O O O
89 Am not interested in other people's problems. O O O O O
90 Rush into things. O O O O O
91 Get stressed out easily. O O O O O
92 Keep others at a distance. O O O O O
93 Like to get lost in thought. O O O O O
94 Distrust people. O O O O O
95 Know how to get things done. O O O O O
96 Am not easily annoyed. O O O O O
97 Avoid crowds. O O O O O
98 Do not enjoy going to art museums. O O O O O
99 Obstruct others' plans. O O O O O
100 Leave my belongings around. O O O O O
101 Feel comfortable with myself. O O O O O
102 Wait for others to lead the way. O O O O O
103 Don't understand people who get emotional. O O O O O
104 Take no time for others. O O O O O
105 Break my promises. O O O O O
106 Am not bothered by difficult social situations. O O O O O
107 Like to take it easy. O O O O O
108 Am attached to conventional ways. O O O O O
109 Get back at others. O O O O O
110 Put little time and effort into my work. O O O O O
111 Am able to control my cravings. O O O O O
112 Act wild and crazy. O O O O O
113 Am not interested in theoretical discussions. O O O O O
114 Boast about my virtues. O O O O O
115 Have difficulty starting tasks. O O O O O
116 Remain calm under pressure. O O O O O
117 Look at the bright side of life. O O O O O
118 Believe that we should be tough on crime. O O O O O
119 Try not to think about the needy. O O O O O
120 Act without thinking. O O O O O
Innacurate Moderately 
Innacurate
Neither Moderately 
Accurate
Accurate
M5-120 Questionnaire
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APPENDIX I 
Correlation Tables for Emotion Recognition Accuracy 
Correlations between Schizotypy, Cannabis Use, Cannabis-Related Problems, and 
Emotion Recognition Accuracy 
Schizotypy and 
Cannabis 
Variables 
Total 
Accuracy 
Score 
Sad 
Accuracy 
Happy 
Accuracy 
Neutral 
Accuracy 
Disgust 
Accuracy 
Angry 
Accuracy 
Positive  
Schizotypy 
-.147 .015 .244* -.249* -.082 -.149 
Disorganized 
Schizotypy 
-.095 .061 .364**  -.301* -.041 -.098 
Negative 
Schizotypy 
-.065 .045 -.031 -.077 -.022 -.099 
Total  
Schizotypy 
-.133 .044 .262* -.271* -.066 -.144 
Cannabis-Related 
Problems 
-.009 .008 -.058 .036 -.048 -.017 
Cannabis Use 
Frequency 
.133 .076 -.027 .132 -.038 .109 
*p < .05, **p < .01 
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Correlations between Personality and Emotion Recognition Accuracy 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Personality Domains 
and Facets 
Total Sad Happy Neutral Disgust Angry 
Extraversion -.127 -.165 -.038 -.038 .049 -.069 
Friendliness .004 -.078 .007 .063 .037 -.015 
Gregariousness -.013 -.075 -.008 .014 .017 .058 
Assertiveness -.082 -.099 -.020 -.084 .152 -.067 
Activity -.034 .078 -.027 -.107 .154 -.183 
Excitement-Seeking -.272* -.236* .042 -.110 -.164 -.136 
Cheerfulness -.099 -.250* -.201 .109 -.007 .086 
Agreeableness .085 .085 -.060 .029 .106 .014 
Trust .109 -.104 -.072 .055 .245* .263* 
Morality -.066 -.015 .067 -.075 -.075 -.023 
Altruism .095 .103 .032 -.025 .154 -.005 
Cooperation .126 .113 -.103 .164 -.042 .019 
Modesty -.059 .110 -.112 -.034 -.044 -.197 
Tendermindedness .166 .159 .017 .038 .172 .002 
Conscientiousness .204 -.058 -.189 .307**  .138 .204 
Self-Efficacy .242* -.108 -.004 .331**  .211 .141 
Order .107 .072 -.171 .066 .113 .130 
Dutifulness .033 -.108 -.089 .138 -.083 .197 
Achievement-Striving -.008 -.172 -.053 .158 .009 .009 
Self-Discipline .180 -.110 -.310**  .360**  .151 .197 
Cautiousness .306* .090 -.143 .302* .167 .216 
Neuroticism -.035 .137 .018 -.100 -.028 -.158 
Anxiety .056 .239* -.054 -.060 .065 -.150 
Anger .002 .051 -.107 .111 -.128 -.088 
Depression .031 .196 .156 -.181 .125 -.155 
Self-Consciousness -.006 -.045 -.147 .099 -.078 .069 
Immoderation -.186 -.037 .186 -.233 -.129 -.119 
Vulnerability -.074 .152 .067 -.186 .007 -.223 
Openness to Experience .139 .177 .141 .037 .037 -.090 
Imagination -.012 .003 .032 .007 .078 -.177 
Artistic Interests .153 .157 .064 .108 .078 -.128 
Emotionality .035 -.021 -.036 .075 .108 -.078 
Adventurousness .055 .036 .170 -.001 -.002 -.022 
Intellect .223 .330**  .089 .010 .152 -.112 
Liberalism .007 .100 .175 -.041 -.263* .046 
*p < .05, **p < .01 
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APPENDIX J 
Correlation Tables for Lateralization Preference 
Correlations between Schizotypy, Cannabis Use Frequency, Cannabis-Related Problems, 
and Lateralization Preference 
 
Schizotypy and 
Cannabis Variables 
Left 
Side Total 
Visit 
Duration 
Right 
Side Total 
Visit 
Duration 
Positive  
Schizotypy 
.073 .047 
Disorganized  
Schizotypy 
.088 -.004 
Negative  
Schizotypy 
.118 .017 
Total 
Schizotypy 
.105 .028 
Cannabis-Related  
Problems 
-.229 -.037 
Cannabis Use  
Frequency 
-.235* -.117 
                                      *p < .05, **p < .01 
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Correlations between Personality and Lateralization Preference 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                             *p < .05, **p < .01 
 
 
 
Personality Domains 
and Facets 
Left 
 
Right 
 
Extraversion    -.067 -.014 
Friendliness -.128 .023 
Gregariousness -.111 -.037 
Assertiveness .126 -.127 
Activity .005 .030 
Excitement-Seeking -.025 .096 
Cheerfulness -.137 -.034 
Agreeableness -.086 -.115 
Trust -.024 .024 
Morality -.141 -.044 
Altruism .036 -.296* 
Cooperation -.106 -.031 
Modesty -.016 -.159 
Tendermindedness -.070 .036 
Conscientiousness -.012 -.063 
Self-Efficacy .104 -.086 
Order -.104 -.070 
Dutifulness -.146 .025 
Achievement-Striving .005 -.115 
Self-Discipline -.048 -.019 
Cautiousness .115 .002 
Neuroticism -.039 -.087 
Anxiety -.124 -.016 
Anger -.008 -.084 
Depression .100 -.009 
Self-Consciousness -.021 -.031 
Immoderation -.004 -.156 
Vulnerability -.089 -.090 
Openness to Experience -.009 -.073 
Imagination -.080 .025 
Artistic Interests .028 -.046 
Emotionality .102 -.374**  
Adventurousness -.078 .134 
Intellect .031 -.093 
Liberalism -.035 .021 
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APPENDIX K 
Correlation Tables for Emotional Feature Fixations 
Correlations between Schizotypy, Cannabis Use Frequency, Cannabis-Related Problems, 
and Facial Feature Fixation for Neutral and Happy Faces 
Schizotypy and 
Cannabis-
Related 
Variables 
Neutral Faces 
 
Happy Faces 
 
Fixation 
Duration 
 
Fixation 
Count 
Fixation 
Duration 
 
Fixation 
Count 
Eyes  Mouth  Eyes Mouth  Eyes  Mouth  Eyes Mouth  
Positive  
Schizotypy 
-.093 .094 -.044 .041 -.015 -.005 .018 -.087 
Negative  
Schizotypy 
.060 .094 .086 .084 .068 .017 .114 .012 
Disorganized 
Schizotypy 
-.038 .249* .015 .233 .010 .199 .066 .145 
Total  
Schizotypy 
-.047 .173 .006 .136 .015 .079 .067 .014 
Cannabis Use 
Frequency 
-.217 -.012 -.175 .066 -.192 .017 -.174 -.022 
Cannabis-Related 
Problems 
-.255* .128 -.266* .211 -.250* .125 -.252* .101 
*p < .05, **p < .01 
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Correlations between Schizotypy, Cannabis Use Frequency, Cannabis-Related Problems, 
and Facial Feature Fixation for Angry and Disgust Faces 
 
     *p < .05, **p < .01 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Schizotypy and 
Cannabis-
Related 
Variables 
Angry Faces 
 
Disgust Faces 
 
Fixation 
Duration 
Fixation 
Count 
Fixation 
Duration 
Fixation  
Count 
Eyes Mouth  Eyes Mouth  Eyes Mouth Eyes  Mouth  
Positive 
Schizotypy 
-.001 .150 .036 .122 -.048 .112 .010 .053 
Negative 
Schizotypy 
.139 .107 .191 .141 .110 .205 .115 .194 
Disorganized 
Schizotypy 
-.005 .258* .043 .260* .053 .274* .073 .245* 
Total  
Schizotypy 
.036 .209 .089 .206 .026 .223 .065 .177 
Cannabis Use 
Frequency 
-.183 .053 -.097 .024 -.223 -.009 -.192 .031 
Cannabis-Related 
Problems 
-.188 .243* -.160 .208 -.255* .177 -.252* .209 
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Correlations between Schizotypy, Cannabis Use Frequency, Cannabis-Related Problems, 
and Facial Feature Fixation for Sad Faces 
 
 
 
 
 
 
 
 
 
 
 
                      *p < .05, **p < .01 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Schizotypy and Cannabis-
Related Variables 
 
Sad Faces 
Fixation  
Duration 
Fixation 
Count 
Eyes  Mouth  Eyes  Mouth  
Positive  
Schizotypy 
-.120 .038 -.097 -.035 
Negative 
 Schizotypy 
.091 .058 .064 .014 
Disorganized  
Schizotypy 
-.049 .259* -.003 .216 
Total 
 Schizotypy 
-.058 .137 -.035 .070 
Cannabis Use  
Frequency 
-.143 .034 -.126 .040 
Cannabis-Related  
Problems 
-.216 .228  -.247* .200 
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Correlations between Personality and Facial Feature Fixation for Neutral and Happy 
Faces 
Personality Domains 
and Facets 
 
Neutral Faces 
 
Happy Faces 
 
Fixation 
Duration 
Fixation 
Count 
Fixation 
Duration 
Fixation 
Count 
Eyes Mouth Eyes Mouth Eyes Mouth Eyes Mouth 
Extraversion -.188 .018 -.231 .132 -.166 .061 -.131 .146 
Friendliness -.186 -.022 -.216 .052 -.176 -.014 -.200 .048 
Gregariousness -.126 -.105 -.196 -.032 -.094 -.042 -.058 .000 
Assertiveness -.115 .009 -.152 .097 -.064 -.031 -.002 .096 
Activity -.087 .076 -.021 .123 -.096 .106 -.076 .144 
Excitement-Seeking -.011 .214 -.040 .268* -.043 .227 -.004 .223 
Cheerfulness -.217 -.111 -.270* -.004 -.187 .002 -.200 .058 
Agreeableness -.033 -.177 .085 -.072 .107 -.040 .117 .017 
Trust -.042 -.072 -.114 -.055 -.045 -.024 -.081 -.038 
Morality -.044 -.192 .139 -.096 .140 -.011 .186 .023 
Altruism -.176 -.051 -.061 .046 -.126 -.015 -.036 .044 
Cooperation .017 -.181 .080 -.084 .079 -.119 .086 -.027 
Modesty .041 -.122 .185 -.071 .212 -.006 .207 .045 
Tendermindedness .055 -.055 .088 -.014 .104 .014 .062 -.004 
Conscientiousness -.019 -.258* -.023 -.168 -.030 -.203 .036 -.122 
Self-Efficacy -.026 -.096 -.002 .008 -.038 -.041 .046 -.015 
Order -.099 -.176 -.086 -.070 -.052 -.105 .003 -.018 
Dutifulness .015 -.278* .022 -.193 .005 -.269* .064 -.227 
Achievement-Striving -.185 -.104 -.069 -.052 -.073 .008 .035 .024 
Self-Discipline .028 -.280* -.041 -.170 -.036 -.274* -.056 -.150 
Cautiousness .171 -.189 .085 -.228 .057 -.204 .070 -.165 
Neuroticism .000 -.028 .028 -.125 .107 -.025 .047 -.105 
Anxiety .055 -.079 .050 -.152 .136 -.005 .051 -.093 
Anger -.025 -.021 .064 -.050 .007 -.043 .067 -.036 
Depression .150 .078 .185 -.003 .224 .052 .187 -.017 
Self-Consciousness .068 -.203 .051 -.309**  .168 -.161 .103 -.264* 
Immoderation -.200 .144 -.231 .049 -.089 .102 -.170 .029 
Vulnerability -.060 -.016 -.016 -.063 .017 -.031 -.038 -.059 
Openness to Experience .080 -.043 .022 -.089 .133 .034 .073 -.104 
Imagination .036 -.074 .049 -.055 .153 .027 .079 -.001 
Artistic Interests .129 -.010 .022 -.035 .168 .082 .085 -.063 
Emotionality -.085 -.021 .013 .075 -.030 -.097 .015 -.024 
Adventurousness .046 .037 -.004 -.021 -.009 .071 .026 -.058 
Intellect .066 -.049 -.110 -.196 .067 .004 -.049 -.137 
Liberalism .075 -.058 .097 -.062 .110 .019 .129 -.050 
*p < .05, **p < .01 
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Correlations between Personality and Facial Feature Fixation for Disgust and Angry 
Faces 
Personality Domains 
and Facets 
Disgust Faces Angry Faces 
Fixation 
Duration 
Fixation 
Count 
Fixation 
Duration 
Fixation 
 Count 
Eyes Mouth Eyes Mouth Eyes Mouth Eyes Mouth 
Extraversion -.158 .013 -.186 .082 -.251* .058  -.299* .093 
Friendliness -.184 -.084 -.178 -.023 -.216 -.012 -.266* -.016 
Gregariousness -.100 -.097 -.148 -.050 -.185 -.070 -.215 -.073 
Assertiveness -.119 .080 -.134 .160 -.142 .031 -.150 .126 
Activity -.087 .047 -.032 .045 -.202 .087 -.179 .096 
Excitement-Seeking .013 .200 -.032 .206 -.068 .246* -.095 .245* 
Cheerfulness -.131 -.106 -.187 -.033 -.182 -.071 -.244* -.020 
Agreeableness -.061 -.116 .103 -.134 -.017 -.176 -.018 -.124 
Trust -.033 -.140 -.047 -.124 -.053 -.082 -.101 -.101 
Morality .042 -.117 .107 -.116 -.066 -.227 -.018 -.133 
Altruism -.166 -.082 -.075 -.045 -.180 -.056 -.154 -.013 
Cooperation .099 -.161 .089 -.100 .065 -.183 .047 -.109 
Modesty .155 -.046 .181 -.060 .086 -.057 .150 -.057 
Tendermindedness .087 -.095 .107 -.064 .047 -.083 -.032 -.065 
Conscientiousness -.027 -.225 -.027 -.174 -.100 -.277* -.114 -.205 
Self-Efficacy -.026 -.102 .012 -.061 -.072 -.124 -.086 -.051 
Order -.035 -.059 -.047 -.029 -.172 -.170 -.178 -.088 
Dutifulness -.058 -.360* -.081 -.310* -.092 -.312* -.092 -.279 
Achievement-Striving -.096 -.052 -.045 -.040 -.212 -.129 -.146 -.077 
Self-Discipline -.051 -.287* -.069 -.192 -.049 -.303* -.089 -.235 
Cautiousness .104 -.181 .081 -.174 .131 -.190 .076 -.186 
Neuroticism -.001 -.042 .055 -.090 .057 -.013 .096 -.053 
Anxiety .015 -.116 .053 -.183 .046 -.074 .041 -.115 
Anger -.043 -.060 .081 -.035 -.005 -.038 .128 -.019 
Depression .115 .111 .149 .060 .263* .129 .244 .102 
Self-Consciousness .101 -.188 .091   -.249* .086 -.208 .108 -.243* 
Immoderation -.147 .132 -.156 .075 -.151 .150 -.128 .077 
Vulnerability -.044 -.028 .008 -.034 -.003 .080 .016 -.016 
Openness to Experience .175 -.028 .086 -.129 .132 .009 -.020 -.062 
Imagination .169 -.003 .136 -.029 .165 .060 .092 .0039 
Artistic Interests .164 -.038 .061 -.143 .137 .046 -.038 -.012 
Emotionality -.049 -.080 .009 -.029 -.041 -.037 .016 -.013 
Adventurousness .105 .039 .048 -.029 -.002 .015 -.098 -.061 
Intellect .123 -.018 -.068 -.143 .116 .004 -.153 -.115 
Liberalism .108 -.047 .101 -.138 .084 -.077 .080 -.080 
*p < .05, **p < .01 
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Correlations between Personality and Facial Feature Fixation for Sad Faces 
 
 
 
 
 
 
 
Personality Domains 
and Facets    
Sad Faces 
Fixation 
Duration 
Fixation  
Count 
Eyes Mouth Eyes Mouth 
Extraversion -.166 .030 -.086 .114 
Friendliness -.191 .039 -.183 .082 
Gregariousness -.090 -.092 -.040 -.034 
Assertiveness -.107 -.068 -.048 .016 
Activity -.117 .108 -.033 .162 
Excitement-Seeking -.017 .217 .023 .218 
Cheerfulness -.113 -.089 -.041 -.003 
Agreeableness .028 -.054 .109 -.004 
Trust -.023 -.141 -.013 -.070 
Morality .015 -.010 .102 -.034 
Altruism -.136 .082 .005 .109 
Cooperation .085 -.123 .134 -.076 
Modesty .031 .012 .022 .039 
Tendermindedness .130 -.022 .200 .008 
Conscientiousness .022 -.207 .081 -.151 
Self-Efficacy .085 -.045 .205 .018 
Order -.069 -.117 -.026 -.067 
Dutifulness -.026 -.292* -.023 -.255* 
Achievement-Striving -.090 -.011 -.023 -.255* 
Self-Discipline .051 -.258* .076 -.159 
Cautiousness .137 -.198 .110 -.191 
Neuroticism .005 .011 -.039 -.047 
Anxiety .034 -.053 -.004 -.103 
Anger .062 .010 .125 .040 
Depression .104 .107 .062 .046 
Self-Consciousness .127 -.199 .064 -.240* 
Immoderation -.230 .148 -.309** .081 
Vulnerability -.085 .051 -.129 -.013 
Openness to Experience .141 .110 .089 .032 
Imagination .095 .043 .067 .034 
Artistic Interests .165 .130 .087 .045 
Emotionality -.018 .020 .051 .054 
Adventurousness .028 .138 -.006 .085 
Intellect .105 .033 .004 -.082 
Liberalism .128 .012 .146 -.047 
*p < .05, **p < .01 
